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Chapter 1 
Serum cholesterol, serotonin metabolism, and violent death: A review 

Introduction 
A high serum cholesterol level is a well documented risk factor for athero-
sclerotic cardiovascular disease. [1 ,2,3,4] Consequently, a low serum cholesterol 
has in general been viewed as beneficial. However, since the early 70s, results from 
several cohort studies and randomized trials have suggested that low or lowered 
cholesterol may increase the risk of dying from non-atherosclerotic causes. A 
number of reviews discussing the putative association between low serum 
cholesterol levels and increased mortality has been published.[5,6,7,8,9] 
These reviews focused mainly on the possibility of a causal relation between low 
cholesterol and mortality from cancer. Although cancer mortality remains an 
important issue, the scope of recent studies on the association between low or 
lowered cholesterol and mortality has broadened towards all non-cardiovascular 
causes of death including accidents, violence and suicide.[10, 11,12,13,14] 
In the present paper the evidence is reviewed for an association between low 
or lowered cholesterol levels and aggression, impulsivity and (mortality from) 
suicide. Both studies addressing 'naturally' occurring low cholesterol levels and 
studies in which a low cholesterol was the result of (drug) intervention are 
discussed. This distinction is important from an etiological point of view, notably 
because a 'naturally' occurring low cholesterol reflects the lower end of the 
cholesterol distribution while lowered cholesterol levels of patients with 
hypercholesterolemia are still in the upper part of the distribution. Moreover, the 
duration of being 'exposed' to lower cholesterol levels is longer in those with 
'naturally' occurring low cholesterol levels compared to those with 'lowered' 
cholesterol concentrations. 
The currently most important hypothesis to explain an association between 
naturally occurring low cholesterol and violent death, involving dietary induced 
serotonin changes as a mediating factor, is discussed in detail. 
RESULTS FROM STUDIES ON LOW SERUM CHOLESTEROL AND VIOLENT 
DEATH 
* Nonexperimental studies 
In nonexperimental, e.g. observational, studies participants/patients with 
different cholesterol levels are followed to compare subsequent mortality risk (table 
I, figure 1). In these studies participants are included with cholesterol levels as they 
occur naturally, and no predetermined interventions take place. 
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Table I. Cohort studies with separate mortality categories 'suicide', 'Ilon~med!cal deaths' or 'unnatural 
deaths' (only males considered, unless otherwise IndIcated). 
Study Particip. (deaths) FU (yrs) Chol. level Effect measure Mort. category p-value 
MRFITII 350,977(21,499) 12 RR suicide 
< 4.14(ref.) 1.0 
4.14- 5.15 0.67 
5.17-6.18 0.58 
2. 6.21 0.64 
2. 4.14 0.62 P < 0.05 
Sweden" 26,693(n.a.) 20.S (quart. means) RR suicide 
1 - 6 5.3 4.22 
6.1 2.39 
6.7 1.99 
7.6(re(,) 1.00 p (trend) = 0.001 
7· 13 5.3 J.65 
6.1 1.30 
6.7 1.20 
7.6 J.()() NS 
14 - 20 5.3 0.66 
6.1 0.66 
6.7 0.78 
7.6 J.()() NS 
Whitehall ll 17,718(4,022) 18 (quintiles) mort./IOOO py suicide 
< 3.34 0.13 
3.34·4.50 0.14 
4.51- 5.14 0.11 
S.15- 5.91 0.15 
> 5.92 0.09 NS 
China" 9,021(595) (9+&) 8 - 13 (quartiles) obsJexp. non-medical 
< 3.53 1.55 
3.54- 4.10 1.44 
4.11-4.62 0.85 
:? 4.63 0.23 P (trend) < 0.05 
Finlafld'~ 1,580(n.a.) 25 (tertiles) mort./IOO,OOOpy aC<:./violence 
(Eastern) < 6.24 175.9 
6.25~ 7A1 178.1 
~7A2 57.0 NS 
(Western) <6.05 128.4 
6.06- 7.11 136.9 
> 7.12 240.7 NS 
ace. : accidents mort. : mortality py : person-years 
<:hol. : cholesterol NS : not significant quart. : quartile 
FU : fo!lol .... -up obs.lexp. : observed/expected ref. : reference category 
fl.a. : not available particip. : participants 
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Figure 1. Cholesterol and violent death (cohort studies) 
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In the Whitehall Study, plasma cholesterol levels were measured in 17,700 
London civil servants. [15] During a follow-up period of over 20 years, 
noassociation was observed between cholesterol levels and death from suicide or 
all violent deaths. In two Finnish cohorts of the Seven Countries Study conflicting 
results were obtained.[16] A statistically non-significant, inverse association 
between serum cholesterol and mortality from suicide was observed in one cohort 
and a statistically significant, positive association in the other cohort. In a Chinese 
study with average cholesterol values far below those generally seen in Western 
populations a marginally significant inverse relationship between serum cholesterol 
concentrations and deaths attributed to non-medical causes was observed.[17] 
However, the total number of deaths in this category was small and after taking 
confounding variables into account the association became weaker. A recent 12 
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year follow-up analysis of 350,000 men screened in the Multiple Risk Factor 
Intervention Trial showed that the death rate from accidents, suicides and homicides 
was significantly higher for men with cholesterol levels below 4.14 mmoljl (about 6% 
of the participants) compared to men with higher cholesterollevels.[18J Of the 
three categories of violent death, only suicide was significantly associated with 
serum cholesterol level. In a Swedish cohort with a follow-up period of 20.5 years, a 
strong inverse relationship between cholesterol levels and mortality from injuries 
was observed in men during the first seven years of follow-up only.[19J 
Recently, in a report of a National Heart, Lung, and Blood Institute (NHBLI) 
sponsored conference on Low Blood Cholesterol and Mortality Associations, 19 
cohort studies were considered in a formal quantitative review.[12, 13J Results from 
the individual studies were adjusted for differences in age, diastolic blood pressure, 
cigarette smoking, body mass index, and alcohol intake, when available. The risk 
for combined non-cardiovascular non-cancer causes of death decreased steadily 
across the range of total cholesterol. The risk ratio among men with serum 
cholesterol levels below 4.14 mmoljl was 1.32 compared to those with a cholesterol 
level between 4.14 and 5.15 mmoljl (no confidence interval given). This mortality 
category included deaths due to respiratory and digestive diseases, trauma and 
residual causes of death. The latter two categories showed risk ratios of 1.40 and 
1.43, respectively. Exclusion of early deaths from the analysis (to account for the 
potential effect of preexisting illness on the entry cholesterol level and on 
subsequent disease relations) did not materially change the results. 
In the NHANES I Epidemiologic Follow-up Study (NHEFS) the relative risk of 
non-cardiovascular non-cancer mortality in men with a cholesterol level below 4.1 
mmoljl compared to those with a cholesterol of 4.1 to 5.1 mmol/I was 2.1 (95% CI 
1.3 - 3.2) in the first 10 years of follow-up. [20J After 10 years of follow-up the 
relative risk decreased to 1.2 (95% CI 0.6 - 2.5). 
In the Renfrew and Paisley survey total mortality was not related to cholesterol 
level. [21 J There was a highly significant positive association between cholesterol 
level and mortality from coronary heart disease. However, this association was 
counterbalanced by inverse relations between cholesterol levels and cancer and 
'other causes of death' (non-coronary heart disease non-cancer mortality). In 
women the association between cholesterol and 'other causes of death' was more 
pronounced (p = 0.02) than in men (p = 0.07). 
A study among 3,000 Dutch male and female civil servants which was initiated 
in 1953-54 also showed an inverse relationship between serum cholesterol and 
'death from external causes'.[22J In the first 15 years of follow-up a rate ratio of 
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3.7 (95% CI 0.8-17.2) was observed in the lowest cholesterol tertile (,; 6.3 mmoljl) 
compared to the highest cholesterol tertile (;, 7.3 mmoljl). The rate ratio decreased 
to 2.4 (95% CI 1.0-5.4) after 28 years of follow-up. 
In summary, several non-experimental studies reported an association 
between 'naturally' occurring low cholesterol levels and consequent (long-term) risk 
of violent death. A potential hypothesis underlying this association involving dietary 
induced serotonin changes (figure 2) will be discussed in detail later in this review. 
* Experimental studies 
Muldoon et al. performed a meta-analysis on the effect of cholesterol lowering 
on total and cause-specific mortality in trials of primary prevention of coronary heart 
diseases.[11 J Some characteristics of these trials are shown in table 11.[23,24, 
25,26,27,28,29J In total 24,847 men with an average age of 47.5 years 
were included in the meta-analysis amounting to 119,000 person years of follow-up 
and 1,147 deaths. The decrease in mortality from cardiovascular diseases in men 
receiving cholesterol· lowering intervention compared to control subjects was of 
borderline statistical significance (odds ratio (OR) 0.85, 95% confidence interval (CI) 
0.69-1.05). Total mortality appeared not to be affected by treatment (OR 1.07, 95% 
CI 0.94-1.21). This was mainly due to an increase in deaths from unnatural causes 
in the intervention groups (OR 1.76, 95% CI 1.19-2.58). This higher proportion of 
mortality from accidents, suicide or violence was demonstrated in all individual 
studies included in the analysis. Separate analyses of dietary and drug intervention 
trials showed similar results. 
In a subsequent pooled analysis, Davey Smith and Pekkanen [30J added 
the Finnish Mental Hospital study [31J, a large cross· over trial of dietary 
intervention in hypercholesterolemic patients and results from the Expanded Clinical 
Evaluation of Lovastatin (EXCEL) study.[32J Moreover, they used a different 
method of meta-analysis. From this analysis, the estimated risk of violent death 
associated with dietary intervention was not significantly increased (OR 1.20, 95% CI 
0.75-1.93). In the cholesterol lowering drug trials, however, an increased risk of 
death from injury was demonstrated in the treatment groups compared to the 
control groups (OR 1.75, 95% CI1.07-2.85). This finding suggests that lowering 
cholesterol by drugs rather than lowering cholesterol level per se may be related to 
an increased risk of violent death. 
The individual deaths due to accidents, violence and suicide in two primary 
prevention trials, the Lipid Research Clinics Coronary Primary Prevention Trial and 
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Table H. Trials (primary and secondary prevention) with 'unnatural' or 'nonmedical' m0rtc;lity categories reported separately (onty males considered). 
StUdy Intervention Duration of Number of Total number No. of deaths from p-value Mortality Remarks 
follow-up (yrs) participants of deaths unnatural causes category of interest 
interv. contI". interv . contI". intcrv . contI". 
PRIMARY PREVENTION 
LAVA'Zl diet 8 424 422 174 177 4 0 P < 0.05 <rnuma > 6 yrs in trial 
Minnesota24 diet 1.1- 2 2197 2196 158 153 21 14 NS external causes 
Finnish MHlO diet 6 902 928 188 217 13 18 NS accidents I poisoning cross-over trial 
! violence 
WHO" clofibrnte 5.3 5331 5296 128 87 18 15 NS accidents! violence 
13.2 720 650 47 41 NS post-trial included 
Upjohn26 colestipol 1.9 548 546 17 27 2 0 NS accidents 
LRC-CPPT-"" cholestyramine 7.4 1906 1900 68 71 11 4 P < 0.05 accidents I suicide 
homicide 
LRC-CPPl"" 13.4 143 156 11 8 NS POst-trial included 
Helsinki HS~ gemiibrozil 5 2051 2030 45 42 10 4 0.05 < P < 0.10 accidents! violence 
SECONDARY PREVENTION 
CDI'" niacin 6.2 1119 2789 277 723 8 15 NS non-medical 
15 582 1623 12 24 NS post-trial included 
clofibrnte 6.2 1103 2789 288 723 5 15 NS non-medical 
15 637 1623 11 24 NS POst-trial included 
StockhoIrtt~ clofibrate I 5 279 276 61 82 3 NS non-CVD non-cancer 
nicotinic acid 
LAVA: Los Angeles Veterans Administration 
Finnish MH: Finnish Menw Hospital StUdy 
LRC-CPPT: Lipid R=h Clinics - Coronary Primary Prevention Trial 
Helsinki HS: Helsinki Hean StUdy 
CDP: Coronary Drug Project 
NS: non-significant (p > 0.10) interv.: intervention group coutr.: control group 
the Helsinki Heart Study, were examined in detail.[33J After considering dropouts 
and known risk factors such as alcohol intoxication and psychiatric histories, the 
authors conclude that little evidence remains to support the hypothesis that 
cholesterol-lowering drugs are causally related to deaths due to homicides, 
suicides, and accidents. 
For most secondary prevention trials (trials in participants with manifest 
cardiovascular disease), deaths due to accidents, suicide or violence have not been 
reported separately. In the Coronary Drug Project, conducted between 1966 and 
1975 to assess long-term efficacy and safety of lipid-influencing drugs, notably 
clofibrate and niacin, the 'nonmedical mortality' (including accidents, homicide and 
suicide) in the niacin treated group was 25 to 30% higher than in the placebo 
treated group both during and after the treatment phase (8/1119 vs 15/2789 and 
12/1119 vs 24/2789 respectively) (table 1I).[34J The same tendency may have 
been present in the Stockholm Study among hypercholesterolemic patients with 
prior myocardial infarction (3/279 vs 1/276).[35J In this study, however, accidental 
and violent death was not distinguished from other non-cardiovascular and non-
cancer deaths. 
A meta-analysis of both primary and secondary prevention studies could not 
demonstrate a beneficial effect of cholesterol lowering on overall mortality. [36J 
Trials for which figures on mortality from non-medical causes were available showed 
an increased risk of violent death in those treated with cholesterol·lowering drugs 
(OR 1.55, 95%CI1.11-2.16). 
A recent meta-analysis of cholesterol lowering trials (both primary and 
secondary prevention trials) revealed another interesting phenomenon. [37J The 
trials performed in 'Iow·risk' populations, defined by a low risk of dying from 
coronary heart disease in the control group of the trial, showed an increased 
mortality risk in the treated compared to the control group (OR 1.22, 95% CI 1.06-
1.42). In the drug and dietary trials among high risk patients cholesterol lowering 
significantly reduced mortality (OR 0.74, 95% CI 0.60-0.92). Mortality from causes 
other than coronary heart disease was increased in the drug trials (OR 1.21, 95% CI 
1.05-1.39), but not in non-drug trials (OR 1.02,95% CI 0.88-1.19). In the drug trials 
among lower risk patients an increased non-coronary heart disease-mortality was 
observed (OR 1.27, 95% CI1.05-1.53), whereas the trials in higher risk groups did 
not show a significant association (OR 1.14,95% CI 0.92-1.41). This effect 
modification by baseline risk is reflected in the higher death rates in the non-
cardiovascular non-cancer categories in the trials reviewed by Muldoon[11 J, as 
these trials mainly comprised low risk participants. 
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The inconsistent results from drug and dietary intervention studies with respect 
to the effect on mortality from non-natural causes make it difficult to conceive a 
single explanation for the possible association between lowered cholesterol levels 
and violent death. Potentially adverse drug reactions rather than cholesterol 
lowering per se are implicated. Moreover, any attempt to propose a common 
explanation for findings in trials and observational studies should consider the 
different parts of the cholesterol distribution that participants in these different 
studies are in. 
STUDIES ON LOW SERUM CHOLESTEROL LEVELS AND BEHAVIOUR 
* Animal studies 
So far, only one study addressed the association of cholesterol levels and 
behaviour in animals. Kaplan et al. assigned 30 male monkeys to one of two dietary 
conditions: a relatively high fat, high-cholesterol diet or a relatively low fat, low-
cholesterol diet, both diets having the same energy content. [38] After a 22 
months intervention period the serum cholesterol levels were 3.8 and 12.1 mmol/I 
respectively. The occurrence of 21 behavioural acts frequently exhibited by 
monkeys in captivity was monitored. Only contact aggression differed between the 
two groups, with those on the low cholesterol diet exhibiting more aggression than 
the animals on the high cholesterol diet. The interpretation of this study, however, is 
hampered by a lack of baseline data concerning behaviour of the monkeys. 
Moreover, it is not clear whether this study should be classified as a study on the 
influence of low cholesterol or of lowering of cholesterol on behaviour. In addition, it 
is difficult to deduce which part of the diet was responsible for the observed 
discrepancies, since the diets differed in more aspects than the percentage of 
dietary fat and cholesterol. 
Some animal experiments have been conducted to study the effects of specific 
changes in fat composition on behaviour.[39,40,41] Effects on rat behaviour, 
including physical activity and learning abilities were observed and changes in 
fluidity and cholesterol content of cell membranes within the central nervous system 
were reported. 
* Human studies 
Until now, few studies have addressed the relationship between serum cholesterol 
levels and behaviour in humans. Although some of these studies were conducted 
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long ago and some others apply to specific groups only, they consistently 
demonstrated a tendency of a higher prevalence of aggression with lower 
cholesterol levels. In one of the first studies higher cholesterol levels were observed 
among men who were particularly adherent to social norms, who placed high value 
on being dependable and conscientious, and who controlled their impulses 
compared with men without these characteristics. [42] Virkkunen measured serum 
cholesterol fasting concentrations in 274 subjects with personality disorders, of 
whom 139 were found to have an antisocial personality.[43] The group of subjects 
with an antisocial personality had a considerably lower mean level of serum 
cholesterol compared to a group with other personality disorders and a group of 
normal subjects. In another study by the same author the relationship between 
serum cholesterol and behaviour in 280 male homicidal offenders was 
assessed.[44] Of these, 73 had an antisocial personality and 100 had an 
intermittent explosive disorder (according to criteria laid out in the Diagnostic and 
Statistical Manual III). Both groups had a habitual tendency to violence under the 
influence of alcohol. A third group did not show this tendency to violence. Under 
the age of 30, the first two groups showed a markedly lower level of serum 
cholesterol compared to the third group. In another study among 47 boys with an 
attention deficit disorder of whom 22 also had an aggressive conduct disorder the 
cholesterol level in the 22 boys with aggressive conduct disorder was clearly lower 
(mean 3.75 ± 0.51 mmoljl) than in the other 25 boys (mean 4.90 ± 0.61 mmol/I; p 
< 0.001).[45] 
It should be noted that in most of the studies mentioned above, important 
potential confounders such as physical activity, and drug and alcohol use, were not 
taken into account. Recently, in a sample of 1,592 men and women aged 55-74 
years from the Edinburgh Artery Study fasting lipid levels were related to personality 
characteristics as measured by the Bedford Foulds Personality Deviance 
Scales. [46] In this study, serum cholesterol levels were not significantly 
associated with aggression in men. However, serum triglyceride levels were 
positively related to hostile acts and a domineering attitude, especially in men (p < 
0.001). In women, a weaker association with domineering attitude was present (p < 
0.05). 
In a study by Morgan et aI., plasma cholesterol and Beck Depression 
Inventories (BDI) were obtained from 1,020 participants in a cohort of white men 
aged 50 - 89 years.[47] Among the men aged 70 years and older, categorically 
defined depression (BDI score ;;, 13) was three times more common in those with 
. low cholesterol levels than in those with higher concentrations (5/31 vs 22/363, P = 
Low cholesterol 19 
0.03). The inverse relationship between BOI scores and plasma cholesterol 
persisted after adjustment for several possible confounders such as age, health 
status and number of chronic illnesses. 
In the Whitehall II Study hostility was measured by means of the Cook-Medley 
hostility scale.[48] No association between cholesterol concentration and hostility 
scores was demonstrated, either in male or in female participants. Other 
behavioural characteristics were also studied in this cohort by means of the General 
Health Questionnaire (GHQ).[49] Cases (defined by what the authors described 
as a "chronic scoring method") and non-cases showed a negligible difference as to 
their cholesterol level. 
In a recent study the relationship between low cholesterol levels and 
depressive symptoms in elderly people (aged 71 and over) was assessed. [50] In 
both men and women severe depressive symptoms (as defined by Centers for 
Epidemiologic Studies' depression scale) were clearly associated with low 
cholesterol levels « 4.14 mmoljl). After adjustment for several potential 
confounders (weight loss, drug use, physical function) however, the association 
weakened markedly and lost statistical significance. 
Most of the studies mentioned above indicate that low cholesterol levels are 
associated with a tendency towards aggressive behaviour and depression. It is not 
ciear, however, whether this association is causal. A low cholesterol level could 
merely act as an indicator of conditions associated with aggressive behaviour and 
depression. 
In general, no specific attention has been paid to (changes in) behaviour in 
experimental studies in humans. Several cases of deterioration of pre-existent 
psychiatric problems and cases of a sudden occurrence of depression after the 
initiation of using cholesterol lowering drugs (mainly HMG-CoA-reductase inhibitors) 
have been reported.[51 ,52] The Family Heart Study included an evaluation of 
the behavioural changes following a 5-year dietary intervention program. They 
measured changes in negative emotions (including depression and aggressive 
hostility) by means of the Hopkins Symptom Checklist (SCL-90).[53] Participants 
who changed their dietary habits to a less fat-containing diet showed a significant 
decrease in their cholesterol levels (p = 0.024) compared with those who remained 
on a high-fat diet. In participants with a low-fat diet a significant decrease in the 
SCL-90 score was observed, indicating lower tendency towards depression (p < 
0.05) and aggressive hostility (p < 0.05). 
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HYPOTHESES EXPLAINING THE RELATIONSHIP BETWEEN LOW! LOWERED 
CHOLESTEROL LEVELS AND BEHAVIOUR 
Several studies on the potentially deleterious effects of hypocholesterolemia have 
been conducted, mainly addressing the potential association between low 
cholesterol and cancer. These studies may also provide an explanation for a 
relationship between low cholesterol and behaviour. It has been assumed that 
changes in cholesterol level influence the stability and permeability of cell 
membranes. Marenah et al. tested this hypothesis by studying the lipid content and 
fluidity of blood mononuclear cells in healthy male volunteers with a wide range of 
cholesterol levels (3.2-10.0 mmoljl).[54J No significant differences in the 
cholesterol:phospholipid molar ratio of the cell membrane and relative microviscosity 
could be observed between subjects with high or low cholesterol levels. The 
Investigators concluded that changes in cell membranes are unlikely to occur at 
serum cholesterol levels attainable by dietary or drug treatment of hyperlipidemia. In 
earlier studies, the influence of various cholesterol levels on the permeability of cell 
membranes, especially erythrocyte membranes, has been assessed in 
vitro.[55,56J The results of these studies suggest that changes in the cholesterol 
content of ery1hrocyte membranes in some way can influence the stability and 
permeability. Similar evidence is observed in recent in·vitro studies on nucleated 
cells, in which changes of cholesterol level are induced by using HMG-CoA-
reductase inhibitors [57,58,59J or by cholesterol-rich Iiposomes.[60,61J 
Changes in cholesterol level in these studies lead to a wide range of effects, 
mainly on membrane protein function and thus, in general, on membrane 
permeability. However, it is questionable whether the cholesterol changes in these 
experiments are comparable to changes expected in man. The clinical implications 
of the investigated changes are, therefore, unclear. Besides, it can not be excluded 
that the effects observed after lowering of the cholesterol level may in fact be 
attributable to concomitant drug-induced changes in other metabolic 
processes[62J. 
Although one could speculate that changes in membrane permeability could 
induce changes in tryptophan transport over the blood-brain barrier, it is not 
obvious that membrane permeability is strongly influenced by low serum cholesterol 
levels. Moreover, this 'changing membrane properties'. hypothesis does not provide 
an easy explanation for the putative association between low cholesterol and higher 
risk of violent death. 
On the basis of the results in the meta-analysis on low cholesterol and 
mortality from suicide by Muldoon[11], Engelberg proposed a mechanism for 
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Figure 2. Possible hypothesis underlying the relationship between low cholesterol and violent 
death 164) 
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decreased central nervous system (eNS) serotonin metabolism in subjects with 
decreased cholesterol levels. [63] In a reply on the original article, Salter 
reformulated the hypothesis as follows (figure 2).[64] A reduction in dietary 
cholesterol intake may reflect a reduction in overall fat intake. This results in a 
decrease in serum fatty acids. Since fatty acids and tryptophan (the serotonin 
precursor) compete for a binding site on serum albumin, more tryptophan will be 
bound. As the enzyme catalyzing the synthesis of serotonin (tryptophan 
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hydroxylase) is unsaturated with tryptophan, a decrease in free serum tryptophan 
will lead to a corresponding decrease in brain serotonin synthesis. Central nervous 
system serotonin is mainly thought of as inhibitor of depression, aggression and 
impulsivity. A decrease in brain serotonin levels could induce depression, 
aggression and impulsivity. This could eventually lead to violent death. 
It should be noted that this hypothesis is mainly applicable to cholesterol that 
is lowered through diet. This could also provide an explanation for the putative 
association between a 'naturally' occurring low cholesterol levels and violent death, 
when supposing that the low cholesterol concentration is attained by long-term low-
fat diet. 
It remains to be established whether this hypothesis is applicable to the 
association between low cholesterol levels and violent death observed in some drug 
intervention studies. For drugs like cholestyramine and colestipol the bile acid 
binding capacity leads to less uptake of fat from the intestinal lumen. Serum 
triglycerides remain the same or increase. Clofibrate, gemfibrozil and the HMG-CoA-
reductase inhibitors lower serum triglyceride levels. However, their influence on free 
fatty acids is unclear. Moreover, the way they interact with cholesterol uptake, 
synthesis or excretion makes it improbable that those drugs exhibit similar effects 
on other metabolic pathways. 
SEROTONIN 
• Metabolism of serotonin 
Serotonin, or 5-hydroxy-tryptamin (5-HT), can be isolated from platelets and gastro-
intestinal mucosal cells. About 85% of the body serotonin content is found in the 
gastro-intestinal tract, where most of the serotonin is synthesized. Another 10% is 
stored in platelets, which do not synthesize, but actively take up 5-HT from the 
blood. A small amount of 5-HT can be found in the central nervous system (CNS), 
where it exerts its principal functions. CNS serotonin is synthesized in the brain itself 
from the amino-acid tryptophan (Figure 3). Tryptophan has to pass the blood-brain 
barrier and the presynaptic membrane before being synthesized to serotonin. Under 
normal circumstances, the enzyme tryptophan-hydroxylase, which catalyzes the first 
step in the serotonin synthesis, is not saturated, and the synthesis rate varies 
according to the serum level of tryptophan. Until now, four 5-HT-receptors have 
been distinguished in different tissue types. The 5-HT, receptor is mainly observed 
in the CNS, the 5-HT, receptor in the gastro-intestinal tract and on blood platelets. 
Catabolism of CNS 5-HT to 5-hydroxyindoleacetic acid (5-HIM) mainly takes place 
Low cholesterol 23 














r--,,- CH,-CH, -NH, 
I monorunine oxidase (MAO) 
Y H 













via two enzymatic reactions mediated by monoamine-oxidase (MAO) and aldehyde-
dehydrogenase. The 5-HIAA level in central spinal fluid (CSF) is frequently used as 
an indicator for CNS 5-HT activity. A low 5-HIAA level indicates a low level of central 
nervous system serotonin activity, which could result in an impaired suppression of 
aggression, violence and impulsivity. A frequently used indirect measure for CNS 
serotonin activity is the fenfluramine stimulation test. Oral fenfluramine administration 
causes prolactin to be excreted in the blood. Its level is considered to reflect CNS 
serotonin activity. 
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* Studies on behaviour and serotonin or its metabolites 
The influence of central nervous system serotonin on behaviour has not been 
fully elucidated yet. The main function of CNS serotonin is considered to be the 
control of aggression and impulsivity. Since the mid seventies, the association of 
central nervous system serotonin activity and behaviour has received considerable 
attention. [65,66J Especially the relationship between serotonin and depression 
has been extensively investigated, as well as the association between serotonin and 
aggressive and impulsive behaviour. In general, a decreased CNS serotonin activity 
is associated with depression and impaired suppression of aggression and 
impulsivity.[67J Suicide is often considered as inwardly directed aggression. [68J 
There is growing evidence that decreased CNS serotonin activity leads to a 
tendency towards aggressive behaviour, rather than that it directly induces 
aggressive behaviour. [69J Recent findings suggest that reduced 5-HT activity is 
not associated with aggression in the absence of sufficient arousal. [70J This 
raises the possibility that a decreased 5-HT activity changes the threshold for 
aggressive responses to noxious stimuli rather than that it provokes aggressive 
behaviour. 
In a study among healthy men, the influence of three amino acid mixtures on 
mood was assessed: a tryptophan·free (T-), a balanced (8) and a tryptophan-
supplemented (T +) mixture. [71,72, 73J Depression scale scores were 
significantly higher in the T- group, but no effect was observed on aggression. 
The relationship between psychobiological variables and recidivism in criminals 
was determined by Virkkunen.[74J Recidivists had significantly lower CSF 5-HIAA 
and HVA (hydroxyvanillic acid, a dopamine neurotransmitter metabolite) 
concentrations compared to non· recidivists. Unfortunately, levels of cholesterol were 
not measured. 
In normal volunteers the relationship between CSF 5-HIAA and scores on the 
Hostility and Direction of Hostility Questionnaire was examined. [75J A statistically 
significant inverse association between scores on an 'urge to act out hostility' 
subscale and CSF 5-HIAA levels was observed. Again, however, cholesterol levels 
were not measured. 
In summary, the available studies on serotonin and behaviour suggest that in 
subjects with a tendency towards criminal behaviour or suicide, a decreased CSF 
level of 5-HIAA is present. 
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* Studies on cholesterol and serotonin levels 
Until now only two studies have reported on the association between serum 
cholesterol and (indirect measures for) CNS serotonin metabolism. In a study by 
Muldoon et aI., 9 male monkeys on a low-fat diet were compared with 10 male 
monkeys put on a high-fat diet. [76J After a 7 months intervention period the 
serum cholesterol levels were 4.0 and 10.9 mmol/I respectively. Body weight was 
similar in both groups. The hypothesis that a cholesterol-lowering diet reduces CNS 
serotonergic activity was tested by using the fenfluramine stimulation test. Prolactin 
response levels were significantly lower in the monkeys on a low-fat low-cholesterol 
diet, compared to those on the high-fat high-cholesterol diet. The frequency of 
aggressive behavioural acts was not assessed. The investigators concluded that 
among monkeys on a low-cholesterol, low-fat diet the CNS serotonergic activity and 
responsiveness is lower compared to monkeys on a high-fat, high-cholesterol diet. 
Although similar in tryptophan content, the diets differed in more aspects than 
cholesterol only. It is, therefore, possible that the observed differences are 
attributable to other dissimilarities in the diet. 
In another study, the effect of cholesterol-lowering drugs on several platelet 
functions was evaluated. [77J This study was performed in 12 hypercholesterolemic 
patients treated during 12 weeks with simvastatin which reduces cholesterol 
synthesis through the inhibition of HMG·CoA-reductase activity. In particular, 
intraplatelet serotonin concentration increased towards normal values following the 
initiation of the drug treatment. It is not clear, however, whether platelet serotonin 
changes are related to CNS serotonin changes. [78J 
CONCLUSIONS AND IMPLICATIONS FOR FUTURE RESEARCH 
A low serum cholesterol level has been associated with elevated risks of 
unnatural and violent death. Some studies address the influence of 'naturally' 
occurring low cholesterol levels on behaviour and violent death, others address the 
influence of the lowering of cholesterol levels on behaviour. From an etiological 
point of view this is a crucial difference. The widespread use of cholesterol lowering 
drugs and reports of an association between low cholesterol levels and violent 
death justify a thorough and detailed study of this issue. The limited number of 
investigations performed up to date and the fact that they differ widely in scope and 
methods, make it difficult to draw firm conclusions. The association between low 
cholesterol concentrations and serotonin metabolism is still nebulous, as is the 
association between low cholesterol levels and behaviour. The results from lipid-
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lowering trials are often viewed as evidence of increased risk of violent death 
associated with low cholesterol. 
Cohort studies have provided important evidence of associations between low 
cholesterol and violent death. However, there are several disadvantages of these 
studies. A major limitation is that in general results are not based on a series of 
cholesterol measurements over time. A low cholesterol level in a subject may reflect 
a final stage of a decreasing cholesterol level. Thus, the population of these studies 
may actually consist of two different subpopulations: one with a naturally occurring, 
continuously low cholesterol level and one with a low cholesterol level because of a 
decrease of a higher cholesterol level, for example due to the development of 
cancer. [79] This is the main reason that in many studies the deaths occurring 
within the first 5 or 10 years of follow-up are excluded from the analysis.[15,20,21] 
In Lindberg's study the association of low cholesterol and death from suicide 
attenuated after the first seven years.[19] Another study, however, still observed an 
association after exclusion of the deaths occurring during the first 5 or 10 years.[1B] 
It therefore remains unclear whether a chronically low cholesterol level in itself is a 
hazard to health. One could even doubt whether the procedure of excluding the 
deaths occurring in the first years after the baseline measurement is helpful in 
revealing associations between low cholesterol and violent death. Cancer is 
considered a long term process, and it is questionable whether this is a valid 
approach for violent death. 
Assessment of the influence of low cholesterol levels on violent death in trials, 
however, almost always suffers from insufficient numbers of deaths in the 
categories of interest (suicide, accidents). A careful verilication of these causes of 
death, however, may be very helpful in unravelling some of the mysteries in this 
field. Studying other endpoints, such as behaviour, in experimental studies is of 
clear interest. Therefore, more attention should be paid to changes in behaviour in 
experimental studies, which implies a baseline and follow-up assessment of 
tendencies towards aggression and impulsivity. Consequently, questionnaires 
should be validated and made suitable for use in (large-scale) clinical trials. 
That the effects of a 'low' and a 'lowered' cholesterol level may be different is 
not hypothetical. From the point of view of homeostasis, it is more likely to have a 
imbalance in a certain metabolism (e.g. serotonin) in people who have their 
cholesterol lowered than in those with a long lasting, naturally occurring low 
cholesterol. The latter probably reflects a 'steady state' model. It is therefore of 
crucial importance to distinguish between patients with low or lowered cholesterol 
levels in future nonexperimental studies by using results from multiple cholesterol 
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levels, measured during the follow-up period. Moreover, the cholesterol levels in 
experimental and nonexperimental studies differ widely, the latter ones dealing with 
participants at the low end of the cholesterol level distribution, the former with those 
at the high end of the distribution. It cannot be excluded that the mechanism 
underlying the association between low cholesterol and behaviour or violent death 
may be different for the participants in these two types of study. 
As for possible clues in the association between low cholesterol and violent 
death, it is necessary to measure those characteristics that may be related to both 
the cholesterol level and the occurrence of violent death. For example, in two 
studies a larger proportion of the participants with low cholesterol levels had 
diabetes compared to those with higher cholesterol levels. [80,81 J In addition, 
a possible link of low cholesterol with hepatic synthetic function has been 
suggested, because of a positive relationship between cholesterol levels and 
albumin and factor VII levels. [82J As for these measurements, it is possible that pre-
or co-existent illnesses (one of which is depression) play an important or even 
crucial role in the occurrence of low cholesterol. This was hypothesized by a recent 
analysis by Wald et aI., who found no excess mortality from non-natural causes 
when restricting to cohorts with employed men, i.e. to healthier populations.[14J 
In the only animal study until now addressing the relationship between low 
cholesterol levels and behaviour baseline assessment of behavioural characteristics 
is lacking. This, however, is necessary to interpret behaviour after intervention has 
taken place. Further, the dietary differences within one experiment were not 
restricted to the cholesterol content, and therefore other nutrients could be 
responsible for observed differences in behaviour. A study which combines all 
characteristics of previously conducted (animal) studies could yield more convincing 
results, as well as create a more complete picture of metabolic changes caused by 
intervention. 
There have been many studies of the influence of cholesterol lowering drugs 
on metabolic processes in animals and in men. Unfortunately, similar measurements 
have not been reported from large-scale trials. 
In view of the possible role of serotonin on the association between low 
cholesterol and violent death, baseline and follow-up measurements of serotonin 
metabolism and behaviour should preferably be included in future experimental and 
non experimental studies. This could possibly even reveal the sequence of events: Is 
there already a pre-existent violent death related behaviour, or is this behaviour 
induced by a decrease of the cholesterol level? 
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Chapter 2 
Correlates of chronically low cholesterol levels in healthy middle-aged men 

Introduction 
A chronically elevated serum cholesterol concentration is an established 
independent risk factor for the development of coronary heart disease, and various 
measures have been advocated to lower high cholesterol levels in individuals or 
populations in order to prevent premature cardiac death.[1,2,3,4J Consequently, 
chronically low cholesterol levels are commonly considered healthy and desirable. 
However, in several observational studies subjects with very low cholesterol levels 
appeared to be at an increased mortality risk compared to those with cholesterol 
levels in the normal range. This excess risk was mainly attributable to a higher 
incidence of violent death (suicides, accidents) in the low cholesterol group. 
[5,6,7,8J 
Several hypotheses have been proposed to account for the findings in these 
studies. [9, 1 0, 11 J Although studies aiming at identifying determinants of chronically 
low cholesterol levels could provide additional insight in this issue, only few such 
studies have been performed.[12,13J We compared men with low serum total 
cholesterol levels (,; 4.5 mmoljL) with men with cholesterol levels between 6 and 7 
mmoljL to assess correlates of chronically low cholesterol concentrations. Potential 
determinants studied included dietary habits, drug use, chronic diseases and 
anthropometric measurements. 
Methods 
In 1990 - 1991 a large cholesterol screening study among men aged between 
40 and 70 years was conducted in the Rotterdam metropolitan area. In total, 30,359 
men were screened. Non-fasting blood samples were obtained and cholesterol was 
measured enzymatically.[14J Those men with a serum cholesterol level below the 
fifth percentile of the cholesterol distribution (4.5 mmol/L or lower) were invited in 
1993-1994 to have a second cholesterol measurement, unless they used anti-
diabetic medication or cholesterol·lowering drugs, had kidney- or thyroidal diseases, 
or were known to have cancer. After an overnight fast, blood samples were taken. If 
the cholesterol level was again 4.5 mmoljL or lower, they were selected in the 
study. The reference group consisted of men with a cholesterol level between the 
35th and 75th percentile of the cholesterol distribution (between 6 and 7 mmoljL) in 
the cholesterol screening study in 1990-1991, whose cholesterol level was again 
between 6 and 7 mmoljL in 1993-1994 after an overnight fast. Again, those using 
antidiabetic medication or cholesterol lowering drugs, and those with kidney- or 
thyroidal diseases or cancer were excluded. Subjects from the reference group 
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were selected from the same age category (± 5 years) and socia-economic back-
ground, as indicated by the postal code, as those in the low cholesterol group. 
Of those with a low cholesterol level during the screening survey in 1990-1991, 
75% visited the research centre for a second measurement in 1993-1994. The 
response in the reference group was 71%. After remeasurement of cholesterol 
levels, 47% of the participants with cholesterol concentrations between 6 and 7 
mmol/L during the screening in 1990-1991 was excluded because their cholesterol 
levels were lower than 6 mmol/L. Of the participants with initially low cholesterol 
levels, 33% was excluded after remeasurement because their cholesterol level 
exceeded 4.5 mmol/L. 
Before a second visit to the research centre in 1993-1994, participants from 
both groups completed various questionnaires including questions on physician 
prescribed medication use and chronic diseases, and filled out a semi-quantitative 
food frequency questionnaire.[15] At the research centre all questionnaires were 
checked, a medical history was taken and a physical examination was performed by 
a physician. 
Medication use was coded according to ATC-categories.[16] Specific chronic 
diseases assessed included psychiatric, pulmonary, gastro-intestinal and cardio-
vascular disorders. A history of psychiatric disease was defined as either a self-
reported history of depression, treatment by a psychiatrist or suicide attempt. A 49 
item semi-quantitative food frequency questionnaire was used. Information on 
frequency and mean quantity of main food categories, such as vegetables, fish, 
meat, soup, bread, dairy products, fruits, alcohol use, snacks, and the use of 
specific fats and oils, was obtained.[15] On the basis of these data mean daily 
intake of nutrients could be calculated. Nutrient intake was adjusted for differences 
in energy intake by linear regression analysis. 
The physical examination consisted of measurements of height, weight, blood 
pressure, heart rate, skinfold thickness[17J, and waist and hip circumference. 
Laboratory measurements included serum albumin, HDL-cholesterol and 
triglyceride levels. Serum LDL-cholesterollevel was calculated using the Friedewald 
formula.[18] 
Participants were asked whether they smoked or had smoked in the past, and 
if so, how many cigarettes per day, the age at which they started smoking and the 
estimated amount of cigarettes per day in the period they smoked. Pack years were 
calculated as the years smoked times the mean number of cigarettes per day. One 
pack year was defined as 20 cigarettes per day during one year. 
Differences in means were tested with two group t-tests, unless otherwise 
stated. Chi-square tests were used to test differences in categorical variables. 
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Table 1. Medication use In subjects with low cholesterol levels (s 4.5 mmol/L) (n"130) and 
those with cholesterol levels between 6 and 7 mmol/L (n"130). 
low cholesterol reference two·slded 
group group p-value 
n (%) n (%) 
any medication 41 (32) 38 (29) 0.79 
1 drug 21 (16) 16 (12) 0.48 
2 drugs 10 (8) 13 (10) 0.66 
3 Of more drugs 10 (8) 9 (7) 1.00 
cardiovascular (ATC·C) 13 (10) 12 (9) 1.00 
alimentary tract (ATC·A) 8 (6) 11 (9) 0.63 
respiratory system (ATC·R) 9 (7) 6 (5) 0.59 
nervous system (ATC·N) 9 (7) 10 (8) 1.00 
psycholeptlcs (ATC·N05) 6 (5) 2 (2) 0.28 
psycholeptlcs = antlpsychotlcs, anxlolytlcs, hypnotlcs and sedatives. 
ATC = anatomical therapeutic chemical classlflcatlon Index 
Table 2. Prevalence of chronic diseases In subjects with low cholesterol levels (" 4.5 mmol/L) 
(n"130) and those with cholesterol levels between 6 and 7 mmol/L (n"130). 
low cholesterol reference two·slded 
group group p-value 
n (%) n (%) 
history of psychiatric diseases 7 (5) 8 (6) 1.00 
depression 2 (2) 2 (2) 1.00 
treated by psychiatrist 6 (5) 7 (5) 1.00 
suicIde attempt 1 (1) 0(0) 1.00 
pulmonary diseases 7 (5) 2 (2) 0.17 
gastro-lntesUnal disorders 13 (10) 17 (13) 0.56 
gastric disorders 9 (7) 17 (13) 0.15 
Intestinal dIsorders 4 (3) 0(0) 0.12 
cardIovascular diseases 12 (9) 5 (4) 0.13 
hypertensIon 2 (2) 8 (6) 0.11 
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Results 
The mean age of the 130 participants in each group was 55.1 years (SO 9.4) 
in the low cholesterol and 55.6 years (SO 9.1) in the reference group. 32% of the 
men with low cholesterol levels and 29% of those in the reference group used drugs 
(table 1). For most of the medication groups the differences between the two 
groups were negligible, but psycholeptics, notably anxiolytics (Le. diazepam and 
chlordiazepoxide) were more frequently used by men with low cholesterol levels 
(5% vs 2%; p = 0.28). 
Pulmonary, intestinal and cardiovascular diseases were somewhat more 
prevalent in those with low cholesterol levels, while gastric disorders and 
hypertension were more frequent in the reference group (table 2). However, no 
statistically significant differences in the presence of these chronic diseases were 
observed. 
Table 3. Results of physical examlnallon In subjects with low cholesterol levels (!5: 4.5 mmolJL) 
(n= 130) and those with cholesterol levels between 6 and 7 mmolfL (n=130). 
low cholesterol reference group two·slded 
group p·value 
mean (SEM) mean (SEM) 
height (cm) 176.7 (0.7) 176.2 (0.6) 0.57 
weight (kg) 76.1 (1.1) 77.4 (0.9) 0.34 
BMI (kg/m') 24.3 (0.3) 24.9 (0.3) 0.10 
waIst circumference (em) 91.6 (0.9) 94.6 (0.9) 0.02 
hlp circumference (cm) 99.5 (0.5) 100.9 (0.5) 0.04 
waist/hip ratio 0.92 (0.01) 0.94 (0.01) 0.04 
total sklnfold thickness (mm) 52.4 (1.5) 63.1 (1.5) < 0.001 
biceps (mm) 5.6 (0.2) 7.0 (0.2) < 0.001 
triceps (mm) 9.4 (0.3) 11.2 (0.3) < 0.001 
subscapular (mm) 16.1 (0.6) 19.3 (0.6) < 0.001 
supraillacaf (mm) 21.3 (0.7) 25.6 (0.7) < 0.001 
DBP (mm Hg) 84.5 (1.0) 85.5 (1.0) 0.48 
SBP (mm Hg) 134.5 (1.7) 136.2 (1.5) 0.45 
heart rate (min") 67 (1) 68 (1) 0.41 
SEM '" standard error of the mean DBP = diastolic blood pressure 
BMI = body mass Index SBP '" systolic blood pressure 
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The results of the physical examination are shown in table 3. The most marked 
differences between the low cholesterol and the reference group were found for the 
skinfold thicknesses. In addition, both waist and hip circumference and the ratio of 
these two measurements were lower in the low cholesterol group. Mean body mass 
index was 24.3 kg/m' in the low cholesterol group and 24.9 kg/m' in the reference 
Table 4. Inlake of various nutrients per day In subjects with low cholesterol levels (:s: 4,5 
mmol/L) (n= 130) and lhose with cholesterol levels between 6 and 7 mmol/L (n= 130). 
low cholesterol reference two-sided two-sided 
group group p-value p-value 
adJusted* 
mean (SEM) mean (SEM) 
energy Intake (kJ) 11450 (300) 10970 (280) 0.24 
total protein (g) 106 (3) 104 (3) 0.64 0.37 
vegetable protein (g) 39.1 (1.2) 35.0 (0,9) 0.008 0.01 
total fat (g) 111.9 (3.9) 105.4 (3.5) 0.21 0.65 
saturated fat (g) 43.0 (1.7) 41,1 (1.6) 0.43 0.74 
monounsaturated fats (g) 39,0 (1.4) 37.4 (1.4) 0.42 0.78 
polyunsaturated fats (g) 21.9 (1.0) 19.4 (0.8) 0,04 0.10 
PIS ratio 0,55 (0.02) 0,50 (0.02) 0,06 
linoleic acid (g) 18,3 (0.9) 15.9 (0,7) 0.04 0,09 
cholesterol (mg) 296 (12) 305 (11) 0,58 0,04 
total carbohydrates (g) 301 (9) 274 (8) 0,02 om 
mono-dlsaccharldes (g) 152 (6) 139 (6) 0.12 0.30 
polysaccharides (g) 148 (4) 134 (3) 0,007 0,01 
dietary fiber (g) 21.0 (0.6) 18,7 (0,5) 0.004 0.01 
water (L) 2,68 (0.07) 2.88 (0,09) 0.07 < om 
alcohol (g) 14.4 (1.7) 23.4 (2,3) 0.002 < om 
percentage of energy 
protein (%) 15.5 (0,2) 16,0 (0,2) 0.17 
fat (%) 36.4 (0.7) 35,8 (0,5) 0.47 
carbohydrates (%) 44.3 (0.7) 42,0 (0,6) 0.01 
* :=: adjusted for total energy intake 
SEM :=: standard error of the mean 
PIS ratio = ratio of polyunsaturated fats I saturated fats Intake 
Low cholesterol 39 
Table 5. Serum lipid and albumin levels In sUbjects wllh low cholesterol levels (s 4.5 mmol/L) 
(n=130) and those with cholesterol levels between 6 and 7 mmoljL (n=130). 
low cholesterol reference two·slded 
group group p-value 
mean (SEM) mean (SEM) 
total cholesterol (mmoljL) 3.8 (0.04) 6.6 (0.04) * 
HDL·cholesterol (mmoIjL) 1.14 (0.03) 1.24 (0.03) 0.008 
triglycerides (mmoIjL) 1.13 (0.06) 1.84 (0.07) < 0.001 
LDL·cholesterol (mmoIjL) 2.47 (0.04) 4.99 (0.05) < 0.001 
albumin (giL) 42.8 (0.2) 43.6 (0.2) 0.004 
total cholesteroljHDL'cholesterol ratio 3.56 (0.08) 5.68 (0.13) < 0.001 
LDL-cholesteroIjHDL-cholesterol ratio 2.34 (0.07) 4.34 (0.12) < 0.001 
* selection of groups based on cholesterol level 
HDL = high density lipoprotein 
LDL = low density lipoprotein 
group (p = 0.10). Although both diastolic and systolic blood pressure were lower in 
the low cholesterol group, the differences were not statistically significant. 
Both the individual lipid values and all composite measures to estimate risk for 
cardiovascular disease (such as total cholesterol - HDL ratio and the HDL - LDL 
ratio) were considerably lower in the low cholesterol group (table 5). Albumin level 
was also found to be lower in subjects with low cholesterol levels. 
A comparison between mean intake of several nutrients is shown in table 4. 
The ratio of the dietary polyunsaturated and saturated fats (PIS ratio) which is 
regularly used as indication for the effect of the diet on serum cholesterol levels, 
was higher in the low cholesterol group (mean PIS-ratio 0.55) compared to the 
reference group (mean PIS ratio 0.50; p = 0.06). Daily intake of vegetable proteins, 
carbohydrates (mainly polysaccharide intake) and dietary fiber were all higher in the 
low cholesterol group, while in this group a lower daily intake of water and alcohol 
was observed. The percentage of energy derived from carbohydrates was 
significantly higher in men with low cholesterol levels. Cholesterol intake was lower 
in the low cholesterol group than in the reference group. 
Except for the proportion of never-smokers, which was considerably higher in 
men with low cholesterol levels (24.5%, vs 12.5% in the reference group; p = 0.02), 
no obvious differences in smoking habits were present between both groups. 
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Discussion 
The most marked differences between two groups of men selected on the 
basis of contrasting cholesterol levels (low cholesterol group ,;; 4.5 mmoljL, and 
reference group between 6 and 7 mmoljL) were observed for dietary habits, 
notably intake of vegetable proteins, total carbohydrates, polysaccharides and 
dietary fiber, which were all higher in men with low cholesterol levels, and 
cholesterol, alcohol and water intake, which were lower in the low cholesterol 
group. In addition, skinfold thickness was clearly lower in the low cholesterol group. 
To our knowledge, only two other studies reported on characteristics of 
subjects with low cholesterol levels. Franzblau and Criqui compared the lowest to 
the middle decile (46th to 55th percentile) of the cholesterol distribution in two age 
categories (3D-54 and 55-79 years old). In the oldest age category, the mean 
cholesterol levels were 4.0 mmoljL in the lowest decile (n = 149) and 5.3 mmoljL 
in the middle decile (n = 140).[12] Manolio et al. investigated correlates of low 
cholesterol levels in the Cardiovascular Health Study by comparing men and 
women, aged 65 to 100 years, with cholesterol levels of 4.14 mmoljL and lower 
with those with a higher cholesterollevels.[13] Results of these studies will be 
discussed later on. 
Because of the higher risk of death from violent causes observed in several 
studies,[5,6,7,8] we specifically examined the use of psychotropic drugs. Although 
no difference in the prevalence of psychiatric history was observed between the 
groups, the use of psycholeptic drugs was somewhat more prevalent in the low 
cholesterol group. This could be of importance in view of the supposedly higher risk 
of violent death in those with low cholesterol levels (see chapter 1). 
The proportion of energy delivered by carbohydrates was higher in the group 
with low cholesterol levels, as was the poly-unsaturated - saturated fat intake ratio, 
which may both be partly responsible for the difference in cholesterol levels 
between the two groups.[19,20] Another possible explanation is the difference 
in the vegetable protein intake, which was considerably higher in the low cholesterol 
group. It is known that increased vegetable protein intake leads to decreased 
cholesterollevels.[21,22,23]In addition, fiber intake was higher in the low 
cholesterol group, and this may further shed light on the mechanisms resulting in 
lower serum cholesterollevels.[24,25,26] Alcohol intake was markedly higher 
in the reference group, which is reflected by the higher HDL-cholesterollevels in this 
group.[27,28,29] Our finding of a lower cholesterol intake in those with low 
serum cholesterol concentrations is of particular importance in view of the serotonin 
mechanism proposed to be involved in the low cholesterol-associated increased risk 
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of depression and violent death, where low cholesterol intake is the initial step in the 
causal pathway (see chapter 1).[9,10] However, energy adjusted fat intake, another 
step in this hypothesis, was similar in the two groups. 
In a cross-sectional sample of Framingham males, aged 37 to 70, dietary 
determinants of serum cholesterol were investigated. [30] Positive associations 
with serum cholesterol levels of fat, cholesterol and protein intake were observed. 
Inverse associations with serum cholesterol levels were found for total and simple 
carbohydrate (= mono- and disaccharides) intake. Complex carbohydrates (= 
polysaccharides) showed a marginal correlation with serum cholesterol levels. 
Except for the higher protein intake in subjects with higher cholesterol levels, these 
results are quite similar to those observed in our study. 
As expected, serum triglyceride, HDL-, LDL-cholesterol and the total 
cholesterol / HDL-cholesterol and LDL-cholesterol / HDL-cholesterol ratios were all 
significantly lower in the group of men with low cholesterol levels. These results are 
in accordance with earlier studies. Manolio et al.[13] obtained similar results for the 
lipid levels, and Franzblau and Criqui[12] found a large difference in (12 hour 
fasting) triglyceride levels (1.16 mmol/L in those in the lowest and 1.47 mmol/L in 
the middle decile; p < 0.01). 
Manolio et al. reported low cholesterol to be associated with lower levels of 
hemoglobin and factor VII, and they suggest that this may be linked with hepatic 
synthetic dysfunction. Although we did not measure these two parameters, the 
lower plasma amino acid levels we observed in the low cholesterol group (see 
chapter 3) is in conflict with their findings, because hepatic dysfunction would raise 
amino acid levels. A continuous inverse relation between total cholesterol and factor 
VII activity in elderly subjects was recently reported from the Rotterdam Study.[31] 
In conclusion, there are indications that men with low cholesterol levels differ in 
several aspects from those with a cholesterol level between 6 and 7 mmol/L, 
notably with respect to dietary habits. These factors may playa role in the way 
these low cholesterol levels are achieved. Whether the observed differences playa 
causative role in the reported relationship between low cholesterol levels and the 
risk of depression or violent death remains to be established. 
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Chapter 3 




From several large follow-up studies associations have been reported between 
chronic low cholesterol levels and mortality caused by violence, in particular 
suicide.[1,2,3] A low serum cholesterol and this specific mortality category are 
not necessarily causally related. However, it has been suggested that low 
cholesterol levels may be mechanistically involved in the increased mortality from 
violent causes. Engelberg postulated a role for the neurotransmitter serotonin in this 
relationship and Salter elaborated on this.[4,5] According to these views, low 
cholesterol levels may be accompanied by decreased fatty acid levels in serum. 
Fatty acids are bound to serum albumin, as is most of the serotonin precursor 
tryptophan, a large neutral amino acid. When fatty acid levels decrease, more 
tryptophan will be bound to albumin, and serum free tryptophan levels will 
decrease. As a consequence, there is less supply of this amino acid to the brain, 
where it is used to synthesize serotonin. Low brain serotonin levels have been 
observed in depression and suicide[6,7], and in impulsive and aggressive 
behavior. [8] 
Tryptophan transport across the blood-brain barrier is mediated by a carrier 
within the brain capillary wall, which is also used by the other large neutral amino 
acids (tyrosine, phenylalanine, valine, leucine and isoleucine). The availability of 
tryptophan to the brain is in general thought to be reflected by the tryptophan-ratio, 
I.e. the ratio of the total tryptophan level to the sum of the other large neutral amino 
acids. [9, 1 0] 
To our knowledge, no studies on tryptophan levels and its relationship with 
cholesterol levels in humans are available. We compared levels of tryptophan and 
other large neutral amino acids and the calculated tryptophan-ratio in healthy 
middle-aged men with low serum cholesterol levels (4.5 mmol/L or lower) and a 
reference group of men with cholesterol levels between 6 and 7 mmol/L. 
Methods 
A cholesterol screening study among 30,359 men, aged 40 - 70 years, was 
conducted in Rotterdam in 1990-1991. Non-fasting blood samples were obtained 
and cholesterol was measured enzymaticaIlY.[II] Those men with a serum 
cholesterol level below the fifth percentile of the cholesterol distribution (4.5 mmol/L 
or lower) were invited to have a second cholesterol measurement, unless they used 
antidiabetic medication or cholesterol-lowering drugs, or had kidney- or thyroidal 
diseases or prevalent cancer. After an overnight fasting, blood samples were taken. 
If the cholesterol level was again 4.5 mmol/L or lower, they were selected in the 
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study. The reference group consisted of men with a cholesterol level between the 
35th and 75th percentile of the cholesterol distribution (between 6 and 7 mmol/L) at 
the moment of the cholesterol screening study, whose cholesterol level remained 
between 6 and 7 mmol/L after an overnight fasting. Again, those using antidiabetic 
medication or cholesterol lowering drugs, and those with kidney- or thyroidal 
diseases or prevalent cancer were excluded. 
Subjects from the reference group were selected from the same age category 
(± 5 years) and socia-economic background, indicated by postal code, as those in 
the low cholesterol group. Participants from both groups completed a questionnaire 
including information on medication use and chronic diseases and a self-
administered, semi-quantitative food frequency questionnaire [12], and were 
invited for an additional visit to the research center. At the center, all questionnaires 
were checked, a medical history was taken and a physical examination was 
periormed by a physician. 
Plasma amino acid concentrations were determined by an HPLC method using 
automated precolumn derivatization with o-phthaldialdehyde.[13J The tryptophan-
ratio was calculated by dividing the total tryptophan level by the sum of the levels of 
the other large neutral amino acids. The plasma 'total' tryptophan level was used, 
because the affinity of the blood-brain-barrier transport molecule for tryptophan is 
much greater than the affinity of albumin, and thus transport to the brain of the 
portion of plasma tryptophan bound to albumin is almost as efficient as that of free 
tryptophan. [9, 10J 
The means of the tryptophan level, the other amino acid levels and the 
tryptophan-ratio in the two cholesterol groups were compared by way of two-
sample t-tests or, in case of a non-normal distribution, the Mann-Whitney-U test. 
Multivariate linear regression analyses with amino acid levels as dependent variables 
were periormed to adjust for potential confounders. Results of all analyses were 
expressed as means with standard errors of the mean (SEM). Two-sided p-values 
were used. 
To assess whether the possibly low amino acid levels in subjects with low 
cholesterol concentrations could be attributed to hemodilution, serum albumin levels 
were measured and a multivariate linear regression analysis was periormed 
including both albumin level and an indicator for cholesterol group (low vs 
reference) as independent and amino acid levels as dependent variables in the 
model. 
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Results 
Table 1 shows selected general characteristics of the study population. In 
total, 106 men were included in each group. The mean tryptophan level in the low 
cholesterol group was 44.0 (SEM 0.6) pmoljL, compared to 50.0 (SEM 0.6) pmoljL 
in the reference group (p < 0.001). Reduced levels were also found for the other 
large neutral amino acids (table 2). Compared to the reference group, the 
distribution of tryptophan levels in the low cholesterol group was shifted to the left 
(figure 1). The other large neutral amino acids showed similar shifts in their 
distributions. The results of the measurements of the remaining plasma amino acids 
are shown in table 3. Plasma amino acid levels in the men with low cholesterol 
levels were lower than in the reference group. Figure 2 shows the tryptophan-ratio 
Table 1. General characteristics of the study population (n=212). 
low cholesterol reference two-sided 
group group p·value 
(n = 106) (n = 106) 
mean (SEM) mean (SEM) 
Age (yr) 55.1 (0.9) 55.6 (0.9) 0.75 
Height (m) 176.6 (0.7) 176.0 (0.6) 0.51 
Weight (kg) 76.2 (1.2) 76.6 (1.0) 0.78 
Body mass Index (kg/m') 24.4 (0.3) 24.7 (0.3) 0.38 
Diastolic blood pressure (mm Hg) 84.5 (1.1) 85.8 (1.1) 0.38 
Systolic blood pressure (mm Hg) 134.5 (1.9) 136.8 (1.8) 0.36 
Cholesterol (mmoIjL) 3.8 (0.05) 6.6 (0.05) • 
Nbumln (g/L) 42.7 (0.2) 43.8 (0.2) 0.001 
Smoking (%) 43 40 0.68 
Energy Intake (kJ/day) 11450 (340) 10880 (330) 0.23 
Protein Intake (g/day) 105.6 (3.6) 102.4 (3.3) 0.51 
Carbohydrate Intake (g/day) 300 (10) 275 (9) 0.05 
Alcohol Intake (g/day) 12.9 (1.7) 21.9 (2.4) 0.002 
Fat Intake (g/day) 113.3 (4.4) 104.2 (4.1) 0.13 
* selection of groups based on cholesterol level 
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Figure 1. Distribution of plasma tryptophan concentration In men with low cholesterol levels (" 
4.5 mmoljL) (n" 106) and In men In the reference group (cholesterol levels between 6 
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Figure 2. Distribution of the tryptophan-ratio In men with low cholesterol fevels (" 4.5 mmoljL) 
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Table 2, Large neutral amIno acId plasma levels and tryptophan-ratio In men wIth low cholesterol 
levels (" 4,5 mmol/L) (n~106) and In men In the reference group (cholesterol levels 
between 6 and 7 mmoljL) (n~ 106), 
low cholesterol reference two·slded 
group group p-value 
mean (SEM) mean (SEM) 
Tryptophan (pmoljL) 44.0 (0,6) 50,0 (0,6) < 0,001 
Phenylalanine (pmoljL) 54,5 (0,6) 60,9 (0,6) < 0,001 
Isoleucine (pmoljL) 75.1 (1.2) 81.3 (1.6) 0,002 
Leucine (pmoljL) 120,8 (1.6) 142,3 (2,2) < 0,001 
Tyrosine (pmol/L) 59,3 (1.1) 66,6 (1,0) < 0.001 
Valine (pmoljL) 260,2 (3.7) 282,5 (4.7) < 0,001 
Tryptophan·ratlo· 7.76 (O,tO) 7,99 (0,12) 0.12 
* ratio of tryptophan and the sum of tyrosine, valine, IsoleucIne, leucIne, and phenylalanine 
in the two groups, The mean tryptophan· ratio in the low cholesterol group was 
7,76(SEM 0,10), compared to 7,99 (SEM 0,12) in the reference group, Although this 
difference was not statistically significant (p = 0,12), a shift towards the left is 
observed here as well, Adjustment for serum albumin levels in a multivariate linear 
regression analysis did not materially change the results, 
Discussion 
We observed lower levels of tryptophan and other amino acid levels in a group 
of healthy men with low cholesterol levels (4,5 mmoljL or lower) compared to a 
reference group of men with cholesterol levels between 6 and 7 mmoljL. The 
tryptophan-ratio did not differ Significantly between the two groups, although a 
tendency to a lower ratio in men with low cholesterol levels was present. 
To our knowledge, no other studies investigating the relationship between 
cholesterol levels and tryptophan or other amino acid levels in humans are 
available. Importantly, the mean amino acid levels in our reference group were 
comparable to levels reported for the general population.[13] Several explanations 
may account for the lower levels of tryptophan and tryptophan·ratio observed in the 
low cholesterol group. 
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Table 3, Other plasma amino acid levels In men with low cholesterol levels (" 4,5 mmol/L) 
(n= 106) and In men In the reference group (cholesterol levels between 6 and 7 mmol/L) 
(n= 106), 
low cholesterol reference two-sided 
group group p-value 
mean (SEM) mean (SEM) 
asparagine (Asn) 51,0 (0,8) 54,7 (0,8) 0,001 
serine (Ser) 96,7 (2,0) 100.4 (1.4) 0,14 
glycine (Gly) 185,5 (3,6) 197,5 (4,2) 0,03 
threonine (Thr) 134,7 (2,6) 137,5 (2,3) 0,39 
citrulline (Cit) 37,9 (0,9) 42,7 (0,8) < 0,001 
arginine (Arg) 74,0 (1.6) 81.6 (1.4) < 0,001 
alanine (Ala) 324,5 (7.4) 374,8 (7.4) < 0,001 
taurine (Tau) 40,5 (0,7) 46,0 (0,7) < 0,001 
methionine (Met) 27,5 (0.4) 29,0 (0.4) 0,003 
lysine (Lys) 149,1 (2,5) 180,2 (2,6) < 0,001 
ornithine (Om) 62,9 (1.3) 72,8 (1.5) < 0,001 
aspartic acid (Asp) 4,5 (0,5) 4,3 (0,2) 0,76 
(n = 105) (n = 106) 
glutamic acid (Glu) 49,2 (1.6) 59,1 (2,2) < 0,001 
(n = 105) (n = 106) 
glutamine (Gin) 541.6 (6,2) 603,7 (9,8) < 0,001 
(n = 103) (n = 47) 
histidine (His) 69,5 (0,9) 83,3 (2,0) < 0,001 
(n = 102) (n = 25) 
The results are compatible with the hypothesis proposed by Engelberg and 
Salter, [4,5] According to their view lower cholesterol levels are accompanied by a 
reduced tryptophan availability to the brain and thus may lead to a lower brain 
serotonin level. The lower plasma level of tryptophan and the, although less 
pronounced, decreased availability of tryptophan to the brain (reflected by the 
tryptophan-ratio) in the low cholesterol group are important features, that form the 
essence of the hypothesis, 
Alternatively, the observed lower plasma tryptophan levels among men in the 
low cholesterol group could reflect a hemodilution effect, especially as the levels of 
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the other amino acids were lower as well. Adjustment for possible dilution by 
including albumin levels in the analysis did, however, not change the results. 
Another possible explanation for the association between low cholesterol and 
tryptophan observed in our cross-sectional study may be that plasma amino acid 
levels (including tryptophan) affect cholesterol levels. This could potentially involve 
mediating factors such as thyroxine[14,15J, insulin/glucagon ratio[16J and 
(inhibition of) hepatic cholesterol synthesis[17, 18J. Several animal studies and one 
study in humans investigated the short-term effects of test meals, containing 
proteins from various sources (casein, soy bean, whey) or different amounts of 
protein on lipid levels.[14,15,16,17,18,19,20,21J Casein was shown to increase 
cholesterol levels, while soy bean and whey decreased cholesterol levels. Until now, 
specific cholesterol-lowering amino acids have not been identified, and only short-
term effects of ingested proteins have been studied with a maximum follow-up 
period of 6 weeks.[15J In our study, the mean protein intake in the low cholesterol 
and reference groups was comparable, and adjustment for this intake did not 
influence the findings. Hence, it seems unlikely that cholesterol changes following 
low amino acid levels account for the results, although measurements of intake of 
specific amino acids were not obtained in our study. 
Finally, the cholesterol-tryptophan association could be caused by impaired or 
suboptimal intestinal uptake of amino acids and cholesterol, leading to both low 
amino acid and low cholesterol levels. The number of men with intestinal diseases 
(e.g. Crohn's disease), however, was small (n=4) and they were all in the low 
cholesterol group. Thus, this can not explain the large differences in plasma amino 
acid levels between the two groups. In addition, no difference in defaecation 
frequency, a possible indicator of intestinal diseases or problems, between the two 
groups was present. 
In conclusion, we observed lower plasma levels of tryptophan and all other 
large neutral amino acids, and a tendency to lower values of an index of the 
tryptophan availability to the brain in men with low cholesterol levels compared to a 
reference group of men with cholesterol levels between 6 and 7 mmoljL. These 
results merit further investigation, and provide support for the hypothesis that 
changes in central serotonin metabolism may underlie the reported association 
between low cholesterol levels and violent death. 
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Chapter 4 
Low cholesterol and serotonin metabolism in men 

Introduction 
Recent findings in a number of studies have suggested a relationship between 
low serum cholesterol levels and risk of death from violent causes, notably 
suicide. [1 ,2] To explain a possible association between low cholesterol and 
violent death a role for serotonin metabolism was suggested by Engelberg, and 
subsequently elaborated by Salter.[3,4] According to these views low cholesterol 
levels may be accompanied by a decrease in serum free tryptophan levels. As a 
consequence there is less supply of this amino acid to the brain, where it is used to 
synthesize serotonin. Low serotonin levels have been observed in depression and 
suicide. To our knowledge, no studies have been reporting on serotonin 
metabolism and its relationship with cholesterol levels in humans. 
We compared indices of serotonin metabolism in healthy middle-aged men 
with low serum cholesterol levels (4.5 mmoljL or lower) with a reference group with 
cholesterol levels between 6.0 and 7.0 mmoljL. 
Methods 
A cholesterol screening study among 30,359 men, age 40 - 70 years, was 
conducted in Rotterdam in 1990-1991. Non-fasting blood samples were obtained 
and cholesterol was measured enzymatically. Those men with a serum cholesterol 
level below the fifth percentile of the cholesterol distribution (4.5 mmoljL or lower) 
were invited to have a second cholesterol measurement in 1993-1994, unless they 
used anti· diabetic medication or cholesterol-lowering drugs, or had kidney- or 
thyroidal diseases or cancer. If the overnight fasting cholesterol level was again 4.5 
mmoljL or lower, they were selected in the study. The reference group consisted of 
men with a cholesterol levels between the 35th and 75th percentile of the 
cholesterol distribution (between 6 and 7 mmoljL) at both occasions. Subjects from 
the reference group were selected from the same age category (± 5 years) and 
socia-economic background, indicated by postal code, as those in the low 
cholesterol group. 
Plasma and platelet serotonin levels were measured using a reversed phase 
HPLC method with electrochemical detection. In addition, Kd (dissociation constant, 
in nmoljL) and Bmax (maximal number of binding sites for serotonin on platelets, in 
fmoljmg protein) were assessed. 
Plasma and platelet serotonin levels were measured in 100 subjects in each 
group, and serotonin binding parameters were measured in a random subsample of 
50 subjects of each group. Differences in means were analysed with two-sample t-
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tests, except for skewed distributions, where non-parametric tests (Mann-Whitney) 
were used. 
Results 
Table 1 provides general characteristics and serotonin measures of the two 
groups of men. The plasma serotonin distribution in the men with low cholesterol 
levels was shifted towards the left, with a mean difference compared to the 
reference group of 1.8 nmoljL (p = 0.01). No apparent differences were present for 
the other parameters of serotonin metabolism. 
Table 1. General characteristics and serotonin measures of the study population (n:=200). 
low cholesterol reference two·slded 
(n = 100) (n = 100) p-valuB 
mean (SEM) mean (SEM) 
Age (yrs) 55.0 (1.0) 54.9 (1.0) 0.97 
Body mass Index (kgjm') 24.5 (0.3) 24.6 (0.3) 0.77 
Diastolic blood pressure (mm Hg) 85.7 (1.1) 85.5 (1.1) 0.89 
Systolic blood pressure (mm Hg) 134.8 (1.9) 136.1 (1.8) 0.63 
Cholesterol (mmol/L) 3.8 (0.05) 6.5 (0.05) * 
Smoking (%) 44 41 0.72 
Energy Intake (kJjday) 11375 (350) 10850 (340) 0.29 
Alcohol Intake (gjday) 13.1 (1.8) 21.9 (2.5) 0.Q1 
Fat Intake (gjday) 112.6 (4.6) 104.4 (4.3) 0.20 
Family history 01 depression or suicide (%) 8.0 8.0 1.0 
Parameters of serotonin metabolism 
Plasma serotonin (nmol/L) 9.31 (0.77) 11.10 (0.72) 0.Q1 
Platelet serotonin (nmoljl0' platelets) 2.94 (0.10) 3.01 (0.12) 0.84 
Kd (nmoljL) 0.12 (0.01) 0.12 (0.01) 0.78 
Bmax (fmol/mg protein) 2103 (81) 2148 (103) 0.68 
* selection of groups based on cholesterol level 
Kd '" dissociation constant 
Smax = platelet serotonin uptake capacity 
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Discussion 
The results of our study suggest that plasma serotonin levels are lower in 
untreated men with persistently low serum cholesterol levels compared to a 
reference group drawn from the same non-hospitalized population. 
To our knowledge, this is the first study in humans investigating a potential 
relationship between cholesterol levels and (indirect) parameters for central nervous 
system serotonin metabolism. One study in monkeys [5] showed the animals with 
low cholesterol levels to have lower central nervous system serotonin activity. These 
animals, however, had their cholesterol concentration lowered or increased during 
dietary intervention. The implications of their findings for persistently low cholesterol 
levels are, therefore, unclear. 
In conclusion, our results indicate that serotonin metabolism may be different 
in men with low cholesterol levels. This finding lends support to the hypothesis that 
serotonin metabolism may be implicated in the observed association between low 
cholesterol levels, behavioral changes and violent death. 
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Chapter 5 




Recenlly, a number of studies reported on the inverse relationship between 
cholesterol levels and death from violent causes, notably suicide.[1,2,3,4,5J It 
has been suggested that low cholesterol levels could lead to depression or 
increased risk of suicide, possibly mediated by changes in serotonin 
metabolism. [6,7 ,8J The proposed mechanism would also be responsible for the 
association between cholesterol level and increased aggression observed in several 
studies.[9,10, 11,12,13J Impulsivity has also been associated with suicide 
and aggression, but its relationship with low cholesterol levels has not been 
addressed previously.[14, 15, 16J In addition, serum cholesterol level has 
been shown to be positively associated with 'vital exhaustion'. [17, 18J 
SO far, two cross-sectional studies have addressed the association between 
cholesterol level and depression in older men and in both a higher prevalence of 
depression was found among those with lower cholesterol levels. [19,20J In a 
number of short-term experimental studies among hypercholesterolemic patients, in 
which cholesterol levels were lowered by drugs or diet, a higher mortality from 
violent causes was observed in the intervention group.[21,22,23,24J It has 
been suggested that depression or hostility induced by lowering of cholesterol 
could be involved in this unexpected phenomenon. [25,26J In only one 
experimental (dietary intervention) study behavioral characteristics were measured 
and a statistically significant positive association between lowered cholesterol and 
depression or hostility was observed. [27J 
To study the relationship between cholesterol level and depressive symptoms, 
aggression, impulsivity and 'vital exhaustion', we compared two groups of middle-
aged non-hospitalized men: one group with a low cholesterol level (4.5 mmol/L or 
lower) and one group with a cholesterol level between 6 and 7 mmol/L. 
Methods 
A cholesterol screening study among 30,359 men, aged 40 - 70 years, was 
conducted in the Rotterdam metropolitan area in 1990~1991. Non-fasting blood 
samples were obtained and cholesterol was measured enzymatically.[28J Those 
men with a serum cholesterol level below the fifth centile of the cholesterol 
distribution (4.5 mmol/L or lower) were invited to have a second cholesterol 
measurement in 1993-1994, unless they used anti-diabetic medication or 
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cholesterol-lowering drugs, or had kidney- or thyroidal diseases or cancer. If this 
overnight fasting cholesterol level was again 4.5 mmoljL or lower, they were 
selected for the study. The reference group consisted of men with a cholesterol 
level between the 35th and 75th centile of the cholesterol distribution (between 6 
and 7 mmoljL) at both occasions. Triglyceride levels were also measured in the 
fasting blood sample. Subjects from the reference group were selected from the 
same age category (± 5 years) and socio-economic background, indicated by 
postal code, as those in the low cholesterol group. Participants from both groups 
completed a questionnaire including information on medication use and chronic 
diseases and a semi-quantitative food frequency questionnaire [29J, and were 
invited to visit the research centre. At the centre all questionnaires were checked, a 
medical history was taken and a physical examination was performed by a 
physician. In addition, questions were asked on change of appetite over the last 
year and on weight loss (> 5% of usual body weight) in the previous six months. 
Alcohol use was assessed (in the food frequency questionnaire) by asking the daily 
number of consumptions and multiplied by a standard mean alcohol content per 
consumption. Specific questions were asked about the prevalence of chronic 
diseases, notably pulmonary, gastro-intestinal and cardiovascular disorders. 
Furthermore, participants filled out six psychological questionnaires (table 2), 
comprising a 25-item state-trait impulsivity questionnaire (IMP, based on Eysenck) 
[30J, a 40-item Self Expression and Control Questionnaire (SECQ, in Dutch 'Zelf-
Expressie en Controle VragenIiJst'[31J, based on the Spielberger Anger Expression 
Scale[32]), the 75-item Buss-Durkee Hostility Inventory (BDHI) [33J, the 21-item 
Beck Depression Inventory (BDI) [34J, the 23-item Maastricht Questionnaire (MQ, 
on vital exhaustion, in Dutch 'Maastrichtse vragenlijst') [35], and the 20-item Self 
Analysis Questionnaire (SAQ, in Dutch 'Zelf Analyse Vragenlijst', based on the 
Spielberger State-Trait Anger Scale).[36J For the Beck Depression Inventory two 
cut-points were used to define depression: 15 or above and 17 or above. [37J All 
questionnaires were in Dutch. Subjects with a total score on the vital exhaustion 
part of the Maastricht questionnaire of 17 or higher were considered vitally 
eXhausted.[35J The SDHI was studied on two distinct factors, the experiential 
(resentment and suspicion subscales) and the expressive (assault, verbal and 
indirect hostility, and irritability subscales) factor.[38,39,40] 
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Data analysis 
The mean scores on the psychological questionnaires in the two groups were 
compared applying the Mann Whitney U test, because of their non-normal 
distribution. Differences of categorical variables between the cholesterol groups 
were tested with the chi-square test. For those questionnaire scores with 
established clinical cut-points, a dichotomous variable was created. A multivariate 
logistic regression model was used, with the dichotomized questionnaire score as 
the dependent variable, and adjustment for potential confounders, such as weight 
loss, alcohol use and chronic diseases. 
Associations of serum triglyceride levels with scores on psychological 
questionnaires were also investigated. In the analysis, the logarithm of triglyceride 
levels was used to obtain a normal distribution. 
Results of all analyses are expressed as means or odds ratios (as 
approximations of relative risks) with 95% confidence intervals (95%CI). 
Table 1. General characteristics of the study population (n=255). 
low cholesterol reference 
group group 
(n = 126) (n = 129) 
mean (SEM) mean (SEM) 
Age (yrs) 55.1 (0.8) 55.6 (0.8) 
Height (m) 176.8 (0.6) 176.2 (0.6) 
Weight (kg) 76.4 (1.1) 77.4 (0.9) 
Body mass Index (kg/m') 24.4 (0.3) 24.9 (0.3) 
Diastolic blood pressure (mm Hg) 84.7 (1.0) 85.7 (1.0) 
SystOliC blood pressure (mm Hg) 134.9 (1. 7) 136.5 (1.5) 
Cholesterol (mmol/L) 3.8 (0.04) 6.6 (0.04) 
Smoking (%) 37 45 
Energy Intake (kJ/day) 11450 (300) 10970 (280) 
Alcohol Intake (g/day) 14.7 (1.7) 23.4 (2.3) 
Fat Intake (g/day) 112.1 (3.9) 105.4 (3.5) 
Family history of depression or 7.1 8.5 
suicide (%) 
* selection of groups based on cholesterol level 















Figure 1, DistrIbution of scores on the Beck DepressIon Inventory In men with low cholesterol 
levels (" 4.5 mmoljL) and a reference group of men with cholesterol/evels between 6 
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Table 1 shows relevant general characteristics of the study population. In total, 
130 men were included in each group. Data from psychological questionnaires were 
not available from four participants in the low cholesterol group and from one in the 
reference group, mainly because of language problems. 
The distribution of the Beck Depression Inventory (BDI) scores in the low 
cholesterol and in the reference group is shown in figure 1. Twelve men in the low 
cholesterol group and three in the reference group had scores of 15 or higher, and 
eight and one, respectively, had scores of 17 or higher. When applying these cut-
points of 15 or 17 to classify symptoms of depression, the relative risks of being 
depressed for those In the low cholesterol group compared with the reference 
group were 4.4 (95% C11.2 - 16.1) and 8.7 (95% C11.1 - 70.3), respectively. After 
adjustment for differences in age, recent weight loss, alcohol use, total energy 
Intake, body mass Index and presence of chronic diseases, these relative risks were 
6.1 (95% C11.5 - 24.7) and 15.9 (95% C11.3 - 199.9). 
Low cholesterol 66 
Table 2. Scores on the psychologIcal questionnaires Included In the study 
Questionnaire score medIan median mean mean p-value 
range low chol. reference low chol. reference (npar.) 
group group group group 
IMP (Impulsivity) [21 [ 
trait 11·44 17 17 17.8 17.5 0.30 
state 14·56 17 17 19.0 18.5 0.38 
SECO (anger) [22) 
control anger-In 10·40 31 33 30.9 31.4 0.27 
control anger-out 10·40 33 34 31.7 32.6 0.28 
anger-In 10-40 20 19 20.1 19.9 0.60 
anger-out 10·40 16 17 17.0 18.0 0.19 
BDHI (hostility) [23) 
assault 0·20 5 6 5.4 6.0 0.43 
Indirect hostility 0·18 4 4 4.2 3.9 0.46 
Irritability 0·22 8 8 7.9 7.7 0.79 
negativism 0·10 5 5 5.1 5.2 0.52 
resentment 0·16 2 2 3.6 3.2 0.58 
suspicion 0·20 6 6 6.2 5.9 0.57 
verbal hostility 0·26 12.5 13 12.3 13.2 0.20 
guilt 0·18 9 8 9.1 8.7 0.29 
BDI (depression) [24) 0·63 4 4 5.0 5.1 0.37 
MO (vital exhaustion) [25) 0·42 4 4 6.3 6.7 0.58 
SAO (anger) [26) 
anger-state 10·40 10 10 10.9 10.6 0.27 
anger-trait 10·40 14 13 14.7 14.8 0.87 
IMP = Impulsivity questionnaire 
SECO = self expression and control questionnaire 
(In Dutch: Zell Expressle en Controle VragenllJst (ZECV)) 
BDHI = Buss-Durkee hostility Inventory 
BDI = Beck depression Inventory 
MO = Maastricht questionnaire 
(In Dutch: Maastrlchlse VragenllJst (MV)) 
SAO = Self analysIs questionnaire 
(In DUlch: Zell Analyse VragenllJst (ZAV)) 
chol. = cholesterol 
"par, = non-parametric 
In this multivariate analysis both weight loss (more than 5% in the previous 6 
months) (RR = 6.9 and 18.7, for BOI cut-points 15 and 17, respectively), and lower 
energy intake (per 1000 kJ) (RR = 1.3 and 2.1, for BOI cut-points 15 and 17, 
respectively) were associated with an increased risk of depression. 
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The mean and median scores on the subscales of the Buss-Durkee Hostility 
Inventory (BDHI), the impulsivity questionnaire (IMP), the Self Expression and 
Control Questionnaire (SECQ), the Maastricht Questionnaire (MQ) and the Self 
Analysis Questionnaire (SAQ) in the two groups are shown in table 2. Results for 
these scales were similar in the low cholesterol and the reference group, as was the 
distribution of the scores. In addition, categorization of the scores on these 
questionnaires did not reveal any relevant differences between the low cholesterol 
and the reference group. 
Neither the experiential nor the expressive hostility factors of the Buss-Durkee 
Hostility Inventory differed between the two groups. The anger-in and anger-out 
subscales of the Self Expression and Control Questionnaire showed a positive 
association with serum triglyceride levels (both subscales p = 0.003). No 
associations were observed between triglyceride levels and the scores on the other 
psychological questionnaires. 
Discussion 
In our study among men aged 40 to 70 years we observed a six-fold 
increased risk of depression (defined as a score of 15 or higher on the Beck 
Depression Inventory) among men selected on the basis of a low cholesterol level 
compared to a reference group with a cholesterol level between 6 and 7 mmol/L. 
No clear differences were found in measures of hostility, anger, impulsivity, and vital 
exhaustion. 
In a similar study, Morgan et al. found a significantly higher risk of severe 
depressive symptoms (BOI score ;" 13) among elderly men (70 years or over) with 
a low cholesterol level « 4.14 mmol/L, mean not reported) compared to those with 
higher cholesterol levels (;" 4.14 mmol/L, mean not reported).[19] Brown et al. 
used the Centers for Epidemiologic Studies' depression scale in men and women 
aged 71 and over. [20] In subjects of 80 years and over only, depressive symptoms 
were more common in those with low cholesterol levels « 4.14 mmol/L, mean not 
reported) compared to those with a cholesterol level of 4.14 mmol/L or over (mean 
not reported). However, after multivariate adjustment for self reported health, 
physical function and number of drugs used, this relationship weakened markedly. 
The Beck Depression Inventory and the Centers for Epidemiologic Studies' 
depression scale may differ in their ability to identify depression, although Zich et al. 
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in their report, indicate that the CES-D and the BDI perform similarly as screening 
instruments for depression.[41J 
In contrast to Morgan's and Brown's studies, we neither included a self rated 
health measure, nor did we explicitly ask participants about their physical 
functioning. Adjustment for these factors in a multivariate analysis can be criticized 
as these factors can act as intermediates in the relationship between cholesterol 
and depression, and could, therefore, dilute a true eXisting association. In our 
analysis, adjustment for presence of chronic diseases (mainly gastro-intestinal 
disorders) did not materially change the findings. 
Associations between low cholesterol and depressive symptoms were 
observed in the higher age categories and not in the younger age categories in the 
studies by Brown and Morgan. We, however, observed the same association in 
younger age categories. Food pattern (or changes in food pattern) as potential 
confounders in the relationship between a low cholesterol and depression was not 
investigated in the two previous studies. Adjustment for energy intake in our 
analyses did not change the association between low cholesterol on depression. 
Moreover, none of the participants stated major changes in food pattern over the 
last 5 years. 
No clear differences in hostility between the low cholesterol and the reference 
group were observed in our study. In one other study various types of hostility, 
among which were subscales of the BDHI [12J and expressive hostility (I.e. the sum 
score of the assault, verbal and indirect hostility subscales), showed a significant 
positive association with both total cholesterol and LDL-cholesterol levels. We could 
not confirm this finding, which may be partly attributable to the lack of partiCipants 
with high cholesterol levels in our study. 
Fowkes et al. examined the relationship between serum cholesterol, 
triglycerides and aggression in the general population.[9J In this study the Bedford 
Foulds Personality Deviance Questionnaire was used. Serum triglycerides levels 
were positively associated with hostile acts and domineering attitudes in men, 
Independent of age, cholesterol (total and HDL), cigarette smoking and alcohol 
consumption. Our findings of a positive association between serum triglyceride 
levels and the anger-in and anger-out scores of the Self Expression and Control 
Questionnaire appear to confirm the findings by Fowkes et aI., although the anger-
in and anger-out subscales we used may not be completely equivalent to the 
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'domineering attitude' and 'hostile acts' subscales of the Bedford Foulds Personality 
Deviance Questionnaire. The anger-trait subscale of the Self Analysis Questionnaire 
did not show any relationship with triglyceride levels. The mechanisms underlying 
the correlation between triglycerides and anger remain to be established, although 
some investigators have suggested that aggressive behaviour may lead to 
increased triglyceride levels, mediated by enhanced sympathetic drive.[42] In 
another study, investigating the relationship between lipid levels and anger in 18 to 
30 year old young males, no significant associations between total serum 
cholesterol levels and anger-in and anger-out scales could be observed, but a 
statistically significant positive correlation between HOL-cholesterol and an anger-
out subscale of the Spielberger Anger Expression Scale (p ~ 0.02) was 
present.[13] We could not reproduce this finding in our study (data not shown). 
To our knowledge, one earlier study among 33 male subjects in their thirties 
investigated the relationship between cholesterol levels and vital exhaustion, 
showing a positive relationship between scores on the Maastricht questionnaire and 
cholesterollevels.[17] The different age category and distribution of cholesterol 
levels hamper the comparison of the two studies. We did not observe clear 
differences in scores on the Maastricht questionnaire between the low cholesterol 
and the reference group. 
Although impulsivity is thought to be associated with aggression and 
depression, low cholesterol levels and impulsivity measured with the adapted 
version of Eysenck's questionnaire were not related in our study. We could not 
identify other studies assessing the association between cholesterol levels and 
impulsivity. This might be due to the lack of generally used, reliable questionnaires 
to assess impulsivity. 
It is still unclear how cholesterol levels could influence the occurrence of 
depressive symptoms. It has been proposed that changes in the serotonin 
metabolism of the central nervous system, through decreased availability of the 
serotonin-precursor tryptophan is involved In this process.[S,7] The decreased 
availability of tryptophan to the brain may be induced by an increased binding of 
this amino acid to albumin, as a result of a low cholesterol-induced reduction In 
binding of fatty acids. Fatty acids compete with tryptophan for binding to albumin. 
The association between low cholesterol and depression may have 
implications for the use of cholesterol lowering drugs, although one has to bear in 
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mind that this intervention takes place at levels at the other end of the cholesterol 
distribution than the cholesterol levels included in our study. In some cholesterol 
lowering trials mortality from suicide was significantly higher in the Intervention 
group. If the proposed mechanism is the same for the drug-induced low cholesterol 
levels, suicide should be one of the causes of death which have to be examined 
carefully. Although the number of suicides has always been relatively small, the 
widespread use of cholesterol lowering drugs could quickly increase this number. 
Because of the different points of action of cholesterol lowering drugs it is, however, 
doubtful whether the mechanism through which they would increase the risk of 
suicide is similar. Assessment of baseline and follow-up levels of biochemical 
parameters with possible indicative value for depressive symptoms, such as 
serotonin, could shed light on this matter. 
In conclusion, we observed an increased prevalence of depression among 
men with low serum cholesterol. This may partly explain the observed association 
between low cholesterol and death from violent causes. Future studies are needed 
to reveal the mechanisms to explain this increased risk and demonstrate its causal 
association with chronically low cholesterol levels. 
Low cholesterol 71 
References 
1. Pekkanen J, Nlsslnen A, Punsar S, Karvonen MJ. Serum cholesterol and risk of accidental or 
violent death In a 25 year follow-up: the Finnish cohorts of the Seven Countries Study. Arch 
Intern Med 1989;t49:t589-9t. 
2. Chen Z, Peto R, Collins Rt at al. Serum cholesterol concentration and coronary heart disease In 
a population with low cholesterol concentrations. Sr Med J 1991;303:276-82. 
3. Davey Smith G, Shipley MJ, Marmot MG. Aose G. Plasma cholesterol concentration and 
mortality. The Whitehall study. JAMA 1992;267:70-6. 
4. Neaton JD, Blackburn H, Jacobs 0, et al. Serum cholesterol level and mortality findings for 
men screened In the Multiple Risk Factor Intervention TriaL Arch Intern Med 1992;152:1490-
1500. 
5. Lindberg G, Aastam L, Gullberg B, Eklund GA. Low serum cholesterol concentration and short 
term mortality from Injuries In men and women. Br Med J 1992;305:277-9. 
6. Engelberg H. Low serum cholesterol and suicide. Lancet 1992;339:727-9. 
7. Salter M. Lower serum cholesterol and suicide (Letter). Lancet 1992;339:1169. 
8. Steegmans PHA, Bak AM, Does Evan der, Grobbee DE, Hoes AW. Low serum cholesterol, 
violent death and serotonln·metabollsm: A review. Cardlovasc Risk Factors 1995;5:(ln press). 
9. Fowkes FGA, Leng GC, Donnan PT, Deary IJ, Alemersma AA, Housley E. Serum cholesterol, 
trlglycerldes, and aggression In the general population. Lancet 1992;340:995-8. 
10. Hilibrand M, Foster HG. Serum cholesterol levels and severity of aggression. Psychol Aep 
1993;72:270. 
11. Spitz AT, Hilibrand M, Foster HG. Serum cholesterol levels and frequency of aggression. 
Psychol Rep 1994;74:622. 
12. DUJovne VF, Houston BK. Hostility-related variables and plasma lipid levels. J Behav Med 
1991;14:555-65. 
13. Waldsteln SR, Polefrone JM, Bachen EA, Muldoon MF, Kaplan JR, Manuck SB. Aelatlonshlp of 
cardiovascular reacllvity and anger expression to serum lipId concentrations In healthy young 
men. J Psychosom Aes 1993;37:249-56. 
14. Asberg M, Schalling 0, Traksmann-Bendz L, Wagner A. Psychobiology of suicide, Impulsivity, 
and related phenomena. In Psychopharmacology: Third generaUon of Progress (ed. HY 
Meltzer), New York: Aaven Press, 1987: pp. 655-688. 
15. Aoy A, Llnnolla M. Suicidal behavior, Impulsiveness and serotonin. Acta Psychlatr Scand 
1988;78:529-35. 
16. Coccaro EF, Central serotonin and Impulsive aggression. Br J Psychiatry 1989;155(S8):52-62. 
17. Doornen LJP van, Blokland AW van. The relation of type A behavior and vital exhaustion with 
psychological reactions to real life stress. J Psychosom Res 1989;33:715-25. 
18. Dlest R van, Appels A. Vital exhaustion and depression: a conceptual study. J Psychosom Res 
1991 ;35:535-44. 
19. Morgan RE, Palinkas LA, Barrett-Connor EL, Wingard DL. Plasma cholesterol and depressive 
symptoms In older men. Lancet 1993;341:75-9. 
20. Brown SL, Sallve ME, Harris TB, Simonsick EM, Guralnlck JM, Kohout FJ. Low cholesterol 
concentrations and severe depressive symptoms In elderly people. Br Med J 1994;308:1328-32. 
21. Dayton S, Pearce ML, Hashimoto S, Dixon WJ, Tomlyasu U. A controlled clinical trial of a diet 
high In unsaturated fat In preventing complications of atherosclerosis. Circulation 
1969;40(Supplll):1-62. 
22. Frantz Jr 10, Dawson EA, Ashman PL, Gatewood LC, Bartsch GE, Kuba K, Brewer ER. Test of 
effect of lipid lowering by diet on cardiovascular risk. The Minnesota coronary survey. 
Arterfosclerosls 1989;9:129-35. 
23. Lipid Research Clinics Program. The Lipid Research Clinics Primary Prevention Trial results. f. 
Reduction In Incidence of coronary heart disease. JAMA 1984;251:351-64. 
24. Frick MH, Elo 0, Haapa K, et al. Helsinki heart study: primary prevention trial with gemJlbrozll 
In middle-aged men with dysllpldemla. N Engl J Med 1987;317:1237-45. 
25. Dults N, Bas FM. DepreSSive symptoms and cholesteroi-lowerlng drugs (Letter). Lancet 
1993;341:114. 
Low cholesterol 72 
26. Lechleltner M, Hopplchler F, Konwallnka G, Patsch JR, Braunstelner H. Depressive symptoms 
In hypercholesterolaemlc patients treated with pravastatln (Letter). Lancet t992;340:9tO. 
27. Weidner G, Connor SL, Hollis JF, Connor WE. Improvements In hostility and depression In 
relation to dietary change and cholesterol lowering. The Family Heart Study. Ann Intern Med 
1992;117:820-3. 
28. Gent CM van, Voort HA van der, Bruljn AM de, Klein F. Cholesterol determinations. A 
comparative study of methods with special reference to enzymatic procedures, Clln Chlm Acta 
1977;75:243-51. 
29. Goldbohm RA, Brandt PA van den, Brants HAM, Veer P van 't, Sturmans F, Hermus JJ. 
Validation of a dietary questionnaire used In a large scale prospective cohort study on diet and 
cancer. Eur J Clln Nutr 1994;48:253·55. 
30. Eysenck SB, Eysenck HJ. The place of Impulsiveness In a dimensional system of personality 
description. Br J Soc Clln Psychol 1977;16:57-68. 
31. Maes S, Elderen T van, Ploeg H van der, Spielberger C. Zelf Expressle en Controle Vragenlljst. 
Llsse, the Netherlands: SWets & Zelilinger, 1987. 
32. Spielberger CD, Johnson EH, Russell SF, Crane RJ, Jacobs GA, Worden T J. The experience 
and expression of anger: Construction and validation of an Anger Expression Scale. In Anger 
and hostlflly In cardiovascular and behavioral disorders (Eds MA Chesney, RH Rosenman), 
Washington DC: Hemisphere Publishing Corporation, 1985: pp. 5-30. 
33. Buss AH, Durkee A. An Inventory for assessing different kinds of hostility. J Consult Psychol 
1957;21 :343-9. 
34. Beck AT, Ward CH, Mendelson M, Mock J, Erballgh J. An Inventory for measuring depression. 
Arch Gen Psychiatry 1961;4:561-71. 
35. Appels A, Hoppener P, Mulder P. A questionnaire to assess premonitory symptoms of 
myocardial Infarction. Int J Cardlol 1987;17:15-24. 
36. Ploeg HM van der, Defares PB, Spielberger CD. Handleldlng blj de Zelf Analyse Vragenlljst, 
ZAV. Llsse, the Netherlands: Swets & Zeltllnger, 1982. 
37. Beck AT, Steer RA. Beck depression Inventory manual. New York: Psychological Corporation, 
1987. 
38. Bendig AW. Factor analytiC scales of covert and overt hostility. J Consult Psych 1962;26:200. 
39. MUsante L, MacDougall JM, Dembrowskl TM, Costa PT. Potential for hostility and dimensions 
of anger. Health Psychol 1989;8:343-54. 
40. Bushman BJ, Cooper HM, Lemke KM. Meta-analYSis of factor analyses: An Illustration using the 
Buss-Durkee Hostility Inventory. Person Soc Psych Bull 1991;17:344-9. 
41. Zich JM, Attkisson CC, Greenfield TK. Screening for depression In primary care clinics: the 
CES-D and the BDI. Int J Psychiatry Mad 1990;20:259-77. 
42. Sugden PH. Serum cholesterol, trlglycerldes, and aggression (Letter). Lancet 1992;340:1350. 
Low cholesterol 73 

Chapter 6 
Low serum cholesterol concentrations and the risk of violent death: a prospective 
study in the Netherlands 

Introduction 
A high serum cholesterol concentration is an established risk factor for 
cardiovascular diseases.[1,2,3,4,5J More recently, it has been suggested that 
low cholesterol levels may also be disadvantageous. Especially the possibility that 
low or lowered cholesterol levels are related to violent death (i.e. suicide, fatal 
accidents, homicide) has received much attention.[6,7,BJ 
The objective of our study was to determine the relationship between 
cholesterol levels and violent death in a 9 - 12 year follow-up study in the 
Netherlands. 
Methods 
In 1975 a follow-up study (EPOZ; Epidemiological Preventive Study 
Zoetermeer) was initiated in Zoetermeer, a town in the western part of the 
Netherlands with at that time 60,000 inhabitants. The objective was to study 
cardiovascular and other chronic diseases and their determinants. All 13,462 
inhabitants aged 5 years and over of two districts were invited and only those 
above 20 years of age were considered in this report (response 75.6% (n ~ 
6,547)). Of this cohort, 490 members (7.5%) were lost to follow-up due to migration, 
and because the dates of migration were unknown they were excluded from the 
analysis. Serum cholesterol concentrations were not available in 134 participants. 
Thus, the present analysis includes 5,923 participants (2,769 men and 3,154 
women). The mean follow-up time was 10 years. 
A detailed report on the methods applied has been published previously. [9J 
Serum total cholesterol concentrations were measured at the participants' entry into 
the study, using an automated enzymatic method.[10J 
Information on the vital status and migration of the participants has been 
provided by the municipal authorities since the start of the study. During the follow-
up period the cause of death of participants was reported to the EPOZ research 
centre by the general practitioners working in the area. In case the cause of death 
was not reported by the general practitioner, it was provided by the Netherlands 
Central Bureau of Statistics (CBS). All causes of death were coded according to the 
International Classification of Diseases (ICD-9). The causes of death of participants 
that died before May 1st 1987 are available. 
Cox' regression analysis was applied to assess the association between 
cholesterol and the risk of violent death (ICD-9 990-999), using cholesterol both as 
a continuous and as a categorical variable. A low cholesterol level was defined as a 
serum concentration of 4.5 mmol/L or lower. Adjustments were made for the 
potential confounding effects of age and gender. 
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Results 
At baseline the mean age of the members in the cohort was 45.1 years (SO 
14.7) for men and 46.6 years (SO 16.0) for women. The mean cholesterol level was 
5.8 mmol/L (SO 1.1) for both men and women. The total number of deaths up to 
May 1st 1987 was 576. The number of violent deaths was 22 (13 men and 9 
women). The mean age at (violent) death was 44.6 years (SO 15.8); 45.1 years (SO 
19.2) for men and 44.0 years (SO 9.9) for women. 
Ten deaths were due to suicide (5 males, 5 females), 9 deaths caused by 
accidents (5 males, 4 females), 1 death due to homicide (male) and 1 death due to 
either suicide or an accident (male). For one violent death (male) the specific cause 
of death could not be retrieved. 
After adjustment for differences in age and sex, the relative risk of violent 
death in those with a cholesterol concentration of 4.5 mmoljL or lower compared to 
those with a cholesterol level above 4.5 mmol/L was 2.85 (95% confidence interval 
(GI) 1.01 - 8.05). The relative risk for hypocholesterolemic men and women 
separately was 2.99 (95% GI 0.79 - 11.36) and 2.64 (95% GI 0.52 - 13.6), 
respectively (table 1). An increase in the cholesterol concentration of 1 mmol/L was 
associated with a 34% reduction in the risk of violent death (RR 0.66, 95% GI 0.43 -
1.02). The relationship between cholesterol levels and violent death was similar 
among the younger (20 to 45 years) and older (45 years and over) participants. 
Separate analyses using death from suicide or accidents as the endpoint, 
yielded point estimates of the relative risks associated with low cholesterol levels 
that were similar to the estimates for all violent deaths combined. 




(n " 2,769) 
women 9 
(n " 3,154) 
total 22 
(n " 5,923) 
, adJusled lor dIfferences In age 
.. adjusted for differences In age and gender 
Relative rIsk 01 vIolent death 
(95% Confidence Interval) 
cholesterol ~ 4.5 per I mmoljL 
versus Increase In cholesterol 
> 4.5 mmoljL level 
2.99 (0.79 - 11.36)' 0.58 (0.29 • 1.18)' 
2.64 (0.52 . 13.58)' 0.72 (0.42 . 1.24)' 
2.85 (1.01 - 8.05)" 0.66 (0.43 • 1.02)" 
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Discussion 
In this 9 to 12 year prospective follow-up study of a cohort of 5,923 men and 
women we observed an increased risk of death from violent causes for those with a 
serum cholesterol concentration at baseline of 4.5 mmoljL or lower (RR 2.85, 95% 
CI 1.01 - 8.05). The risk of violent death decreased 34% per 1 mmoljL increase in 
the cholesterol level. 
These results correspond with several earlier reports.[11,12]In the 
Multiple Risk Factor Intervention Trial a strong association between a low 
cholesterol level (4.14 mmoljL or lower) and risk of death from violent causes, 
notably suicide (RR ~ 1.62) was observed, persisting over the 12 year follow-up 
period. In a recent Swedish study, people with the lowest cholesterol levels (5.3 
mmoljL or lower) had the highest risk of violent death (RR ~ 2.75). Again, the 
strongest association was found for death from suicide (RR ~ 4.22), although the 
relative risk was reduced after 7 years of follow-up (RR ~ 1.65). In our study, low 
cholesterol levels were not more strongly related to death from suicide than other 
categories of violent death. The number of deaths in these categories, however, 
was small and 'the statistical power decreased correspondingly. A recent analysis of 
several cohort studies and randomized trials did not show any significant 
relationship between low or (drug- or diet-induced) lowered cholesterol levels and 
death from accidents and suicide. [8] 
Several hypotheses have been proposed to explain the association between 
low cholesterol levels and risk of violent death. In general, these are linked with 
drug-induced lowering of cholesterol levels. Recent meta-analyses show that 
dietary-induced low cholesterol levels are not clearly associated with violent 
deaths.[13] 
In view of the relative lack of dietary or drug interventions in hyper-
cholesterolemic patients at the time of initiation of our study (mid-seventies), our 
estimates are most likely to represent risks associated with 'naturally occurring' low 
cholesterol levels rather than lowered cholesterol levels. As to the hypothesis 
underlying an association between 'naturally occurring' low cholesterol levels and 
violent death, it has been postulated that low cholesterol is related to a reduced 
serotonin production in the central nervous system, which may induce depression 
and eventually lead to violent death (see chapter 1).[14,15] 
In conclusion, the results from our 9 - 12 year follow-up study provide 
evidence that low cholesterol levels are associated with violent death. 
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In this thesis, studies on associations between chronically low cholesterol 
levels, depression and several parameters of serotonin metabolism are described in 
subjects who were not treated with cholesterol lowering drugs. The aim of these 
studies was to shed light on the mechanisms underlying the reported relationship 
between low cholesterol levels and the (increased) risk of mortality from violent 
causes (i.e. suicide and accidents). This inquiry was inspired by a hypothesis 
proposed by Engelberg and Salter (figure 1).[1,2J According to this view a lower 
cholesterol intake may be accompanied by a lower intake of fatty acids. This could 
lead to a drop in plasma tryptophan (the precursor of serotonin) levels, and 
subsequently lower central nervous system serotonin levels, which may increase the 
prevalence of depression, aggression and impulsivity, and eventually the risk of 
death from violent causes. The components of this mechanism studied in this thesis 
included cholesterol intake, tryptophan and other plasma amino acid levels and 
plasma serotonin concentrations (which were all lower in those with low cholesterol 
levels), measures of depression, aggression and impulsivity (higher prevalence of 
depression among those with low cholesterol levels), and mortality from violent 
causes (Increased in those with low cholesterol levels). Although some of the 
parameters measured in our studies only indirectly address the underlying 
mechanism, the observed associations partially confirm the proposed serotonin 
hypothesis. 
To our knowledge this is the first study relating various factors involved in the 
serotonin hypothesis (including tryptophan, plasma serotonin, depression, 
aggression, impulsivity) to cholesterol levels in humans. One animal study showed 
that lowering cholesterol levels resulted in lower central nervous system 
serotonergic activity and higher levels of aggression, but tryptophan levels were not 
measured. [3J 
In a population-based cross-sectional study, we found plasma tryptophan 
levels to be markedly lower in a group of 130 men with low cholesterol levels ("; 
4.5 mmol/L) compared to a reference group of 130 men with cholesterol levels 
between 6 and 7 mmol/L. The tryptophan-ratio, an indirect measure of the 
availability of tryptophan to the brain, was also lower in the low cholesterol group, 
without, however, reaching statistical significance. Interestingly, the serum levels of 
almost all measured amino acids were lower in the low cholesterol group, indicating 
that an impaired intestinal uptake in these men may be responsible for the findings. 
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Preferably, central nervous system serotonin activity should be measured in 
spinal fluid through lumbar puncture. Since this would have greatly reduced the 
participation rate in these healthy, non-hospitalized men, selected plasma and 
platelet serotonin parameters were used to obtain estimates of the (potential) 
differences in serotonin activity between the low cholesterol group and the reference 
group. Of the four plasma and platelet serotonin parameters measured, plasma 
serotonin level was statistically significantly lower in the group with low cholesterol 
levels. One could question the use of plasma as a model for the synaptic cleft in the 
central nervous system. A study in psychiatric inpatients has raised doubt whether 
these plasma biochemical parameters provide a good representation of the 
processes in the brain, because there was little concordance between the central 
nervous system serotonin activity and plasma serotonin parameters.[4J Although it 
remains unclear whether the relationship between low cholesterol and plasma 
serotonin levels we observed is indeed a reflection of a lower brain serotonin 
activity, the findings are indicative for an altered serotonin metabolism in men with 
low cholesterol levels. 
In our study of behavioral and psychological characteristics, the strongest 
association was observed between low cholesterol and presence of depression, as 
defined by the score on the Beck depression inventorY, even after adjustment for 
potential confounders (figure 1). Scores on the other questionnaires (notably those 
regarding aggression and impulsivity) did not reveal clear associations with low 
cholesterol levels. Other studies have shown similar results, using the same or 
equivalent questionnaires_ [5,6J 
The cross-sectional design of our study limits the possibility to definitely 
assess the time-sequence, or time-dependence. The serotonin hypotheSiS assumes 
that a low serum cholesterol is resulting from a low cholesterol and low fat intake. 
We indeed observed a lower (energy-adjusted) cholesterol intake, but no difference 
in fat intake. Although questions were asked about dietary changes in the past (e.g. 
food pattern over the last 5 years, weight loss), it was impossible to assess 
whether, and if so how, the biochemical parameters, such as tryptophan and 
serotonin levels changed over time. 
Although we observed differences in plasma tryptophan(-ratio) level, plasma 
serotonin level and depressive symptoms between the, low cholesterol and the 
reference group, further analyses did not reveal clear relationships between these 
three parameters. This may be due to limitations in sample size or could indicate 
that only part of the hypothesis is correct. The observed associations for these 
biochemical measures were, however, in the expected direction. 
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Obviously, it is unlikely that changes in a single neurotransmitter can fully 
explain the putative association between low cholesterol and depressive symptoms 
or violent death. The complexity of the matter suggests that other, including 
compensatory, mechanisms are involved. Recently, a hypothesis was proposed, in 
which interleukin-2 (IL-2) plays an important role. [7] It is thought that oxidized low 
density lipoprotein Induces IL-2 production, which causes both a decrease in serum 
cholesterol levels and a decrease in pineal gland melatonin production. The latter 
change would lead to depression and suicidal tendency. 
In addition to a cross-sectional study, we performed an analysis of a 
population-based cohort study in the Netherlands with a follow-up period of 9 to 12 
years and observed an increased risk for violent death of those with (untreated) low 
cholesterol levels. A limitation of this study is the use of a single (baseline) 
cholesterol measurement, although misclassification due to errors in individual 
cholesterol measurements is likely to bias the association towards the null. Also, no 
information on tryptophan or serotonin levels and depressive symptoms was 
available. 
In summary, the findings of the studies described in this thesis suggest that 
serotonin may be involved in the reported association between low cholesterol 
levels and violent death, as hypothesized by Engelberg and Salter[1,2], although we 
could not confirm all parts of the suggested causal pathway (figure 1). Further 
investigations of components of this hypothesis and additional causal mechanisms 
might provide more insight in the mechanisms relating low cholesterol levels and 
violent death or depression. 
Clinical Implications 
An elevated risk of depressive symptoms among men with cholesterol levels of 
4.5 mmoljL or lower, compared to those with cholesterol levels between 6 and 7 
mmoljL is a major finding of our study, and might have implications for clinical 
practice. In patients with known chronically low cholesterol levels physicians should 
be aware of potential depressive symptoms. It should be emphasized, however, that 
subjects with low cholesterol levels (i.e. ,;; 4.5 mmoljL) constitute only about 5% of 
the population and that, unless expensive large scale cholesterol screening surveys 
were to be implemented, the vast majority of those with low cholesterol levels 
remains undetected. The estimated prevalence of depression among those with low 
cholesterol levels ranges from 5 to 10%. 
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From a public health point of view, case finding and screening are usually 
aimed at identifying and treating patients with high cholesterol levels. If the serotonin 
mechanism (figure 1) also applies to those whose (high) cholesterol levels are being 
lowered, the potential health impact of cholesterol-related changes in serotonin 
metabolism may be greater than in those with chronically low cholesterol levels. Our 
studies do not provide data on this possibility. In the former group, two questions 
need to be answered. First, does lowering of (high) cholesterol levels cause shifts in 
central nervous system neurotransmitters? Second, if lowering of cholesterol levels 
In itself is without danger, what level of serum cholesterol can be considered 
optimal? Should the target level be as low as possible, or is a level of about 5.0. 
mmol/L to be preferred? The results of our study suggest that a cholesterol level 
below 4.5 mmol/L may have disadvantages. However, no randomized trials have 
been conducted to conclusively show the beneficial and adverse effects of lowering 
cholesterol levels to such extreme values. 
Future research 
We observed some distinct differences, most markedly in food pattern, 
between subjects in the low cholesterol and the reference groups, that could partly, 
though not fully, explain the difference in serum cholesterol concentrations. As for 
the influence of every-day dietary habits on cholesterol levels, the main obstacle is 
the lack of reliable dietary questionnaires. Studies in subjects on a standardized 
food Intake may shed more light on the dietary mechanisms involved in the 
regulation of serum cholesterol levels. Combined food intake and -uptake studies 
could reveal whether cholesterol levels are affected by differences in uptake levels. 
Investigations in family members of those with low (or high) cholesterol levels 
may give opportunities to assess to what extent genetic factors playa role in the 
determination of cholesterol levels. 
Measurement of serum fatty acid levels might also unravel relationships with 
serum cholesterol levels. Biochemical assessment of the equilibrium of fatty acid 
and tryptophan transport on albumin is difficult, because of the strong dependence 
of the measurements of the relevant parameters on temperature and acidity. We, 
therefore, chose to assess the tryptophan ratio. Our finding that mean amino acid 
levels are nearly all consistently lower in those with low cholesterol levels justifies 
studies into the underlying mechanism. The general reduction in the amino acid 
levels suggests that intestinal uptake may be impaired in subjects with lower 
cholesterol levels. Another possibility is that a slight systemic imbalance (in e.g. 
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thyroid or glucocorticoid metabolism) may lead to both low cholesterol levels and 
lower amino acid levels. A low cholesterol level might then merely be a marker for 
such a minor deviation. [8,9J In addition, disturbances in these endocrine systems 
are known to influence human mood, although these minor changes are unlikely to 
lead to overt psychiatric or psychological pathology, except perhaps for depressive 
symptoms. 
In several studies among psychiatric patients cholesterol levels have been 
measured, in particular of those patients with suicidal tendencies.[10, llJ 
Multiple measurements of parameters of serotonin metabolism in these patients 
could further clarify the association between cholesterol levels and both depression 
and suicides. 
To examine subsequent steps in the cascade, it is necessary to obtain central 
spinal fluid samples. Assessment of various substances in this fluid, such as central 
nervous system tryptophan, tryptophan hydroxylase, and serotonin can more easily 
be done in animals. Some serotonin metabolites have already been measured in 
monkeys[3], and these results confirm the serotonin hypothesis. Especially in these 
animal models, ascertainment of behavioral characteristics is difficult, but in man 
measurement of these characteristics is not without problems either. In particular, 
improvement of questionnaires measuring impulsivity and aggression would help to 
disentangle the postulated relationship with low choles,terol levels. 
New imaging techniques, such as the PET (positron emission tomography) 
scan, have opened new possibilities for more direct research, and are becoming 
used more often in studies of metabolic processes, in particular in the central 
nervous system. The potential of these methods for etiological research is 
increasingly being recognized. In the investigations to reveal the effect of (low or 
lowered) cholesterol levels on mood or violent death, detection of metabolic 
changes in the brain by this methodology in subjects selected on the basis of their 
cholesterol level could provide important causal information. 
As for the final step in the cascade, relating low cholesterol levels to violent 
death, it is of importance that in future (population-based) cohort studies all 
potentially violent deaths are carefully recorded and validated. Because of the 
diversity within this death category (that includes suicides, accidents and homicides) 
there is a need to examine associations with each subcategory separately. Because 
of its most direct link to depression, the 'suicide' -subcategory seems most 
important. 
In conclusion, several parts in the postulated serotonin pathway, relating 
chronically low cholesterol levels to depression or violent death, require thorough 
Low cholesterol 88 
investigation. Specific attention should be paid to the role of potential systemic 
metabolic imbalances. 
Because associations between, notably drug-induced, lowering of (high) 
cholesterol levels and death from violent causes have also been observed[12J, it 
is possible that the same serotonin-related mechanisms may be of importance in 
patients with lowered high cholesterol levels. It should be stressed, however, that, in 
contrast to those with chronically low cholesterol levels, these patients are in the 
upper part of the cholesterol distribution and that it seems unlikely that, in view of 
the different actions of the cholesterol-lowering drugs studied, all medications would 
exert their influence on the risk of violent death via the same mechanism. 
Nevertheless, it is of interest to measure pre- and post-treatment parameters of 
serotonin metabolism in future trials on cholesterol-lowering drugs. 
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High cholesterol levels are considered disadvantageous because of their 
association with an increased risk of coronary heart disease morbidity and mortality. 
Consequently, low cholesterol levels are often thought to be beneficial. However, 
evidence is growing that subjects with chronically low cholesterol levels may be at 
an increased mortality risk also. In particular, a higher incidence of death from 
violent causes (I.e. suicide, accidents and homicide) in these subjects has 
repeatedly been reported. 
Chapter 1 reviews the available evidence pertaining to the association between 
low cholesterol levels and violent death. It is emphasized that, in case of lowering of 
cholesterol levels, this regards the upper end of the cholesterol distribution, 
because it concerns subjects with initially high cholesterol levels, whereas subjects 
with chronically low cholesterol levels are in the lower end of the cholesterol 
distribution. 
An increased mortality from violent causes among those with (untreated) 
chronically low cholesterol concentrations compared to those with higher 
concentrations has been reported from several studies. Among those whose (high) 
cholesterol level was lowered (compared to those whose levels remained high) an 
increased risk of violent death has also been reported, although findings are 
conflicting. 
Recently, a hypothesis has been formulated suggesting an important role for 
serotonin as an intermediate factor in the cascade relating chronically low 
cholesterol levels to violent death. In short, a low cholesterol level will, indirectly, 
cause increased binding of free amino acid tryptophan (a precursor in the 
production of serotonin) to albumin. Therefore, less free (unbound) tryptophan will 
be available to the brain, leading to a decrease in brain serotonin synthesis. A 
reduced brain serotonin level is thought to be related to depression, aggression and 
impulsivity. Depressions, aggression or impulsivity, might eventually lead to suicide 
or accidents. 
Several indications for a role of serotonin in the development of depressions 
can be found in the literature. Mood affecting properties of tryptophan have also 
been observed. Experimental behavioral studies in animals are limited, but the 
results of those studies published are in accordance with the hypothesis. Similar 
studies in humans are not available. 
In chapters 2 to 5 the results of epidemiologic research into the various steps 
of the proposed serotonin hypothesis are presented. In these studies 130 men with 
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chronically very low cholesterol levels (lower than or equal to 4.5 mmofjL, below 5th 
percentile of the cholesterol distribution) were studied together with a reference 
group of 130 men with cholesterol levels between 6 and 7 mmofjL (between 35th 
and 75th percentile). Subjects were eligible to be included in one of the two groups 
if their cholesterol concentration was in the same range both during a cholesterol 
screening survey in 1990-1991 and after remeasurement in 1993-1994. They were 
all between 40 and 70 years old, and living in the Rotterdam metropolitan area. 
Subjects from the reference group were selected from the same age category (± 5 
years) and socio-economic background, indicated by postal code, as those in the 
low cholesterol group. 
A comparison of the low cholesterol and the reference group presented in 
chapter 2 showed that differences in intake of a number of nutrients existed 
between the two groups. This provides insight in the way these low cholesterol 
levels may potentially be attained. In particular, a higher intake of dietary fiber, 
carbohydrates and poly-unsaturated fats (relative to saturated fats) was observed in 
men in the low cholesterol group, compared to the men in the reference group. 
Chapter 3 deals with differences concerning the amino acid tryptophan levels 
between the two groups. Plasma tryptophan level was significantly lower in the low 
cholesterol group compared with the reference group {44.0 (SEM 0.6) JlmofjL vs 
50.0 (SEM 0.6) JlmofjL; p < 0.001). The availability of tryptophan to the brain 
{calculated as the ratio of plasma tryptophan level to the plasma level of the five 
other large neutral amino acids competing for the same carrier across the blood 
brain barrier (valine, leucine, isoleucine, phenylalanine and tyrosine)) was somewhat 
lower in those with low cholesterol levels {7.76 (SEM 0.10) vs 7.99 (SEM 0.12); P = 
0.12), which is in accordance with the proposed hypothesis. Unexpectedly, the 
mean level of almost all measured amino acids was lower in the low cholesterol 
group than in the reference group. Adjustment for albumin level to account for a 
possible dilution effect did not change the results. 
Results as to serotonin measurements in the two groups are presented in 
chapter 4. Rather than using central spinal fluid (which would have required a 
lumbar puncture), a model with thrombocytes as its main component was used as 
an approximation of central nervous system presynaptic neurons. Our finding of a 
lower mean plasma serotonin level in the low cholesterol group compared to the 
reference group (9.31 nmofjL and 11.10 nmofjL, respectively; p = 0.01) illustrates 
that serotonin metabolism may be different in subjects with low cholesterol levels. 
Platelet serotonin binding parameters and platelet serotonin levels, however, were 
similar In the two groups. 
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We assessed presence of (symptoms of) depression, aggression, impulsivity 
and vital exhaustion by self-administered questionnaires. The results are presented 
in chapter 5. The prevalence of depression (defined as a score of 15 or higher on 
the Beck depression inventory) was markedly higher in the group with low 
cholesterol levels, even after adjustment for potential confounders (age, body mass 
index, weight loss, alcohol use, energy intake and chronic diseases) (relative risk = 
6.1; 95% CI 1.5 to 24.7). No clear differences between the groups were observed 
for measures of aggression, impulsivity and vital exhaustion. 
Based on cholesterol measurements at entry and on mortality causes in the 
EPOZ follow-up study, the risk of dying from violent causes was examined in those 
with low cholesterol levels (lower than or equal to 4.5 mmoljL) compared to those 
with cholesterol levels higher than 4.5 mmoljL (chapter 6). The risk of violent death 
during the 9 to 12 year follow-up period for those with low cholesterol levels was 
higher than in the reference group (relative risk = 2.85, 95% CI 1.01 to 8.05). 
In the general discussion (chapter 7) inferences from our findings are 
discussed and suggestions for future research are given. Although a limitation of 
our study is its cross-sectional nature, implicating that it is not possible to definitely 
conclude whether low cholesterol levels are a primary cause of the observed 
differences, or a secondary feature of a yet unknown cause, our findings support 
the view that the serotonin hypothesis is involved in the reported association 
between chronically low cholesterol levels and depression or violent death. 
Potentially important future developments and additional research include the use of 
new imaging techniques, genetic investigations and endocrinological studies. 






In het algemeen wordt een hoog cholesterolgehalte als nadelig beschouwd, 
vanwege het verband met een verhoogd risico op coronaire hartziekte en -sterfte. Een 
laag cholesterolgehalte wordt daarom veelal als gunstig gezien. Uit de recente 
medische literatuur komen echter steeds meer signalen dat personen met een 
langdurig laag cholesterolgehalte mogelijk ook een verhoogde sterftekans hebben. 
Vooral een hogere incidentie van sterfte ten gevolge van geweld (su'lcide, ongevallen 
en moord) bij deze person en is herhaaldelijk gerapporteerd. 
In hoofdstuk 1 wordt een overzicht gegeven van de beschikbare gegevens met 
betrekking tot het verband tussen een laag cholesterolgehalte en gewelddadige dood. 
Benadrukt wordt dat, als het om een verlaging van het cholesterolgehalte gaat, zich dit 
in het bovenste gedeeite van de populatie cholesterolverdeling afspeelt, omdat het 
daarbi) personen betrelt die in eerste instantie een hoog cholesterolgehalte hebben, 
terwi)1 personen met langdurig lage cholesterolgehaltes zich in het onderste dee I van 
de cholesterolverdeling bevinden. 
In verschillende onderzoeken is een verhoogde sterfte ten gevolge van geweld 
gevonden bi) degenen met een langdurig laag (onbehandeld) cholesterolgehalte, 
vergeleken met degenen met een chronisch hoger cholesterolgehalte. Bi) degenen bij 
wie het (hoge) cholesterolniveau werd verlaagd (vergeleken met degenen bij wie het 
cholesterol hoog bleef) is ook een verhoogd risico op gewelddadige dood gevonden, 
hoewel de bevindingen tegenstrijdig zijn. 
Recent werd een hypothese gepubliceerd, waarin een belangrijke rol wordt 
toegeschreven aan serotonine als tussenstap in de cascade die lage cholesterol-
gehaltes in verband brengt met gewelddadige dood. In het kort komt het erop neer 
dat een laag cholesterolgehalte indirect leidt tot een toe name in de binding van het 
vrije aminozuur tryptofaan (noodzakelijk voor de vorming van serotonine) aan 
albumine. Daardoor zal er minder van het vrije (niet gebonden) tryptofaan beschikbaar 
zijn voor de hersenen, wat een vermindering van de serotonine-productie in de 
hersenen tot gevolg heelt. Een verlaagd serotonineniveau in de hersenen wordt in 
verband gebracht met depressies, agressie en impulsiviteit. Depressies, al of niet in 
combinatle met agressie en impulsiviteit, zouden uiteindelijk de aanleiding kunnen zijn 
tot zelfmoord of ongevallen. 
In de literatuur zijn diverse aanwijzingen te vinden voor een rol van serotonine in 
het ontstaan van depressies. Stemmingsbe'lnvloedende eigenschappen van tryptofaan 
zijn ook waargenomen. Dierexperimenteel gedragsonderzoek is schaars, maar de 
resultaten van deze studies zijn in overeenstemming met de hypothese. Vergelijkbare 
studies bi) mensen zijn niet voorhanden. 
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In de hoofdstukken 2 tot en met 5 worden de resultaten van epidemiologisch 
onderzoek, dat zich richtte op de verschillende stappen van de voorgestelde 
serotonine hypothese, weergegeven. In deze onderzoeken werden 130 mannen met 
een langdurig laag cholesterolgehalte (lager dan of gelijk aan 4,5 mmoljl, beneden het 
5e percentiel van de cholesterolverdeling) vergeleken met een referentiegroep van 130 
mannen met een cholesterolniveau tussen de 6 en 7 mmoljl (tussen het 35e en 75e 
percentiel). Person en kwamen in aanmerking om in een van de twee groepen te 
worden opgenomen, indien hun cholesterolgehalte zich zowel bij een cholesterol-
screening in 1990-1991, als bij een hermeting in 1993-1994 binnen dezelfde 
grenswaarden bevond. Aile deelnemers waren tussen de 40 en 70 jaar oud en 
woonachtig in of rond Rotterdam. De groepen waren vergelijkbaar v~~r wat betreft 
leeftijd en postcode, als indicator voor sociaal-economische status. 
Een vergelijking van de laag-cholesterolgroep met de referentlegroep (hoofdstuk 
2) liet zien dat er verschillen waren in de in name van een aantal voedings-
bestanddelen. Oit geeft enig inzicht in de wijze waarop deze lage cholesterol-
concentraties mogelijk bereikt zijn. Met name werden een hogere inname van 
voedingsvezel, koolhydraten en meervoudig onverzadigde vetzuren (ten opzichte van 
verzadigde vetzuren) waargenomen bij de mannen uit de groep met laag cholesterol-
gehalte, vergeleken met de mannen uit de referentiegroep. 
Hoofdstuk 3 beschrijft de verschillen tussen de twee groepen met betrekking tot 
de concentratie van het aminozuur tryptofaan. Het plasma tryptofaangehalte was 
significant lager in de laag-cholesterol groep vergeleken met de referentiegroep (44,0 
(standard error of the mean (SEM) 0,6) pmoljl versus 50,0 (SEM 0,6) pmoljl; p < 
0,001). Ook de beschikbaarheid van het tryptofaan voor de hersenen (berekend als de 
verhouding van het plasma tryptofaan niveau met de som van de vijf andere grote 
neutrale aminozuren, die van hetzelfde transporlmechanisme over de bloed-hersen-
barriere gebruik maken (valine, leucine, isoleucine, fenylalanine en tyrosine» was wat 
lager bij degenen met een laag cholesterolgehalte (7,76 (SEM 0,10) versus 7,99 (SEM 
0,12), p = 0,12), hetgeen in overeenstemming is met de hypothese. Opvallend was de 
bevinding dat het gemiddelde van vrijwel aile gemeten aminozuren lager was in de 
groep met een laag cholesterolgehalte dan bij degenen in de referentiegroep. 
Correctie v~~r het albuminegehalte, als indicator voor een mogelijk verdunnings-effect, 
gaf geen verandering in de resultaten. 
In hoofdstuk 4 worden de resultaten beschreven ten aanzien van de serotonine-
bepalingen in de twee groepen. In plaats van liquor (dat een lumbaal-punctie zou 
hebben vereist), werd een model gebruikt met bloedplaatjes, als benadering van 
presynaptische neuron en in het centrale zenuwstelsel, als belangrijkste component. 
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Onze bevinding van een lagere gemiddelde plasma serotonine concentratie bij 
degenen met een laag cholesterol vergeleken met de referentiegroep (respectievelijk 
9,31 nmol/I en 11,10 nmol/I; p = 0,01) illustreert dat het serotonine metabolisme 
mogelijk anders is biJ personen met een laag cholesterolgehalte. De serotonine 
bindingsparameters van plaatjes en serotonine concentratie in plaatjes waren 
vergelijkbaar in de twee groepen. 
Door mid del van vragenliJsten, die door de deelnemers zelf moe stan worden 
ingevuld, werd de aanwezigheid van depressies, agressiviteit, impulsiviteit en vitale 
uitputting gemeten in de twee groepen. De resultaten worden in hoofdstuk 5 
beschreven. Depressie (gedefinieerd als een score van 15 of hoger op de Beck 
depressie vragenlijst) kwam beduidend vaker voor in de groep met een laag 
cholesterolgehalte, ook na correctie voor potentiale verstorende factoren (o.a. leeftiJd, 
Quetelet index, gewichtsverlies, alcoholgebruik, totale energie-inname en chronische 
ziekten) (relatief risico 6,1; 95% betrouwbaarheidsinterval (BI) 1,5 tot 24,7). Er werden 
geen duideliJke verschillen in agressiviteit, impulsiviteit en vitale uitputting gevonden 
tussen de beide groepen. 
In het Epidemiologisch Preventief Onderzoek Zoetermeer (EPOZ), een follow-up 
onderzoek, werd het risico op een gewelddadige dood onderzocht biJ degenen met 
een laag cholesterolgehalte (lager dan of geliJk aan 4,5 mmol/I) in vergelijking met 
degenen met een cholesterolgehalte boven de 4,5 mmol/1. (hoofdstuk 6). Degenen 
met een laag cholesterol hadden een hoger risico op gewelddadige dood gedurende 
de 9 tot 12 jaar durende follow-up periode dan degenen in de referentiegroep (relatief 
risico 2,85; 95% BI 1,01 tot 8,05). 
In de algemene bespreking (hoofdstuk 7) worden de gevolgtrekkingen van onze 
bevindingen besproken en aanbevelingen voor toekomstig onderzoek gedaan. Een 
beperking van ons onderzoek is haar cross-sectionele opzet, hetgeen met zich 
meebrengt dat het niet mogelijk is na te gaan of lage cholesterolgehaltes een primaire 
oorzaak zijn van de gevonden verschillen, of secundair zijn aan een tot nog toe 
onbekende oorzaak. Toch geven onze bevindingen steun aan de serotonine 
hypothese als mogelijke verklaring voor het aangenomen verband tussen langdurig 
lage cholesterol niveaus en depressie of gewelddadige dood. Mogelijk belangriJke 
toekomstige ontwikkelingen en aanvullende onderzoekingen zijn ondermeer het 
gebruik van nieuwe beeldvormende technieken, genetisch onderzoek en 
endocrinologische studies. 
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Zoals gebruikelijk is dit een proefschrilt dat niet zonder de hulp van een aantal mensen 
tot stand gekomen. Allereerst gaat mijn dank uit naar de vele deelnemers die hun 
bereidwilligheld toonden om aan dit onderzoek mee te doen, zonder dat daar iets 
tastbaars tegenover stond. Geen van hen heelt geweigerd de, soms wei zeer 
onverwachte en merkwaardige, vragenlijsten in te vullen. Ik ben hen daarvoor zeer 
erkentelijk. 
Degenen, zonder wie het project niet eens van de grond zou zijn gekomen, professor 
Rick Grobbee en professor Emiel van der Does, hebben vier jaar lang hun best 
gedaan om de sterke kanten em de zwakke plekken in het geheel aan te geven en 
daarin bij te sturen. Na een enige maanden onzekerheid bij de start van het project 
wist Rick me ervan te overtuigen dat ook in de nieuw ontstane situatie er meer dan 
genoeg kans van slagen was. Zijn kunde was het de grote lijn te blijven zien en tevens 
aile puntjes op de i te zetten. 
Dat sen en ander in de loop van de tijd ook voor leken nog steeds duidelijk is 
gebleven, is zonder meer te danken aan de onophoudelijke aanwijzingen van Emiel 
van der Does. Hem ben ik ook dank verschuldigd voer de uitgebreide en vermakelijke 
gesprekken die we over het proefschrilt voerden. 
Een tweetal stafleden heelt me in de vier jaren wat dichter op de huid gezeten. Ik ben 
blij dat zij mijn begeleiders zijn geweest. Annette Bak heelt in de eerste jaren voor 
organisaterische problem en altijd weer oplossingen weten aan te dragen. Bovendien 
gaf ze de aanzet tot en stu ring voor het eerste grote artikel. De afgelopen jaren is de 
inbreng van Arno Hoes snel toegenomen en van wezenlijk be lang geweest. Zonder 
hem was er van analyseren en schrijven aanzienlijk minder terecht gekomen. In tijden 
dat ik niet meer wist of ik nog wei wat op papier kon krijgen, had hij altijd weer een 
paar fraaie en stijlvolle suggesties die enig schot in de zaak brachten. 
Dat degenen met wie je min of meer dagelijks te maken hebt, je tot steun kunnen zijn, 
is in de loop van de jaren meer dan duidelijk geworden. 
In het Romeres-pand heb ik het eerste jaar een gastvrij onderkomen gehad. De 
praktische afhandeling vond plaats op 'Nr. 177', waar Jacqueline, Lorette, Judith, 
Gerard en ik woekerden met de ruimte, en we soms bijna elkaars deelnemers in 
beslag namen. 
Marianne, met wie ik de he Ie periode op de 'hoogbouw' op een kamer heb door-
gebracht, heelt me duidelijk gemaakt dat er naast werk ook nog wei wat anders 
bestaat. Danielle is twee dagen in de week bij ons op de kamer aan het werk. Haar 
humor is niet stuk te krijgen. Maarten, almaar met Parkinson in de weer, gaf me met 
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bonker' te ontko men. Zijn marinetermen, en ziJn kennis van het Belgisch leiden in de 
kamer regelmatig tot vroliJke taferelen. Betere kamergenoten had ik niet kunnen 
wensen. 
Gerda Koelewijn verbleef tiJdeliJk op onze kamer in het kader van een stage voor de 
Oietetiek-opleiding, en zij is van onschatbare waarde is geweest: Zonder haar hulp zou 
ik nu waarschijnliJk nog steeds met de voedingsgegevens in de weer zijn geweest. Ze 
heelt een enorm karwei in korte tiJd weten te klaren. 
Oat een afdeling internationaal georienteerd is, heelt voor- en nadelen. Ik heb er aileen 
profijt van gehad. I wish to thank the fellows who came here in the past few years; it 
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from Zaragoza. I hope he enjoyed our -late evening- discussions as much as I did, it 
gave me the diversion and the strength to keep on going in the first period of the 
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Mijn ouders hebben me aile vriJheid in keuze van opleiding gelaten en de mogelijk-
he den gecreiierd om deze keuze(n) ook praktisch uitvoerbaar te maken. Ik ben ze 
daar erg dankbaar voor. 
Sesmu en Han wi! ik van harte bedanken voor hun enthousiasme, ondanks hun eigen 
drukke bezigheden, mijn vrienden Em paranimfen te zijn. 
Last but not least, is er een aantal goede vrienden op de achtergrond steeds bij 
betrokken geweest, en een enkeling maakte het proces van zeer nabij mee. Ik wil hen 
van harte bedanken voor hun belangstelling, sleun en.advies. Ik hoop het tekort aan 
lijd voor de vriendschap ooit nog Ie kunnen compenseren. 
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